oxprenolol has been researched along with Hypertension in 301 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The paper deals with the study into the benefits of prazosin and trasicor used in arterial hypertension." | 9.06 | [Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor]. ( Damiĭonaĭtene, RA; Kuchinskene, ZZ; Rugenius, IuIu; Steponenene, RV; Vidugiris, AI, 1990) |
| "The effects of two oxprenolol oral osmotic (OROS) delivery systems on heart rate and blood pressure before and during recovery from exercise at a predetermined load were examined in twelve patients with hypertension previously responding to beta-blocker monotherapy." | 9.06 | Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension. ( Brodie, MJ; McInnes, GT, 1988) |
| "Twenty-five patients with moderate essential hypertension (standing diastolic blood pressure 100-125 mmHg, phase 5) completed a single-blind placebo-controlled cross-over study comparing four week periods of treatment with atenolol 100 mg, metoprolol 100 mg, metoprolol durules 200 mg, slow-release oxprenolol 160 mg, and slow-release oxprenolol 320 mg respectively." | 9.05 | Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. ( Hampton, JR; Wilcox, RG, 1981) |
| "Thirty-two patients with moderate to severe essential hypertension whose supine diastolic blood pressure (SDBP) was greater than or equal to 95 mm Hg following 2 weeks' treatment with the optimal dosage of beta blocker-diuretic combination were randomly assigned to the addition of either captopril 25 mg or 50 mg b." | 9.05 | Efficacy of low-dose captopril given twice daily to patients with essential hypertension uncontrolled by a beta blocker plus thiazide diuretic. ( Agabiti-Rosei, E; Alicandri, C; Boni, E; Cinquegrana, A; Fariello, R; Montini, E; Muiesan, G; Muiesan, ML; Zaninelli, A, 1984) |
| "One hundred pregnant women with hypertension (defined as diastolic blood pressure at or above 95 mm Hg) were allocated at random to treatment with methyldopa or oxprenolol and were compared with nonhypertensive controls matched according to parity and gestation at delivery." | 9.05 | Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. ( De Swiet, M; Fayers, P; Fidler, J; Smith, V, 1983) |
| "In 19 men aged 50 with essential hypertension, 18 weeks' treatment with atenolol (n = 9) or oxprenolol (n = 10) increased supine plasma free dopamine concentrations by 78% (p less than 0." | 9.05 | Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension. ( Aakesson, I; Amundsen, R; Eide, I; Eriksen, IL; Kjeldsen, SE; Leren, P, 1983) |
| "An open, randomized crossover study was carried out in 8 patients with accelerated hypertension to compare the antihypertensive efficacy of oxprenolol with that of propranolol." | 9.05 | Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension. ( Fernandez, PG; Galway, AB; Granter, S; Kim, BK; Sharma, JN; Zachariah, PK, 1982) |
| "The effect of a vasodilator (hydralazine), a beta-blocker (oxprenolol) and also their combination, on essential arterial hypertension and plasma renin activity (PRA), was studied." | 9.05 | Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity. ( Siitonen, L, 1980) |
| "In a within-patient comparison of conventional oxprenolol administered twice daily with slow-release oxprenolol administered once daily in the treatment of hypertension, twenty patients previously responsive to beta-blockers took each formulation for 4 weeks, after wash-out periods off beta-blocker of 2 weeks' duration." | 9.05 | Once daily beta-blocker in hypertension--oxprenolol slow-release. ( Gordon, RD; Row, G; Rowe, WS; Strakosch, CR; Ziesak, M, 1981) |
| "48 patients with normal-renin essential hypertension were treated with prazosin alone or in combination with oxprenolol." | 9.05 | Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension. ( Farsang, C; Juhász, I; Kapocsi, J; Székács, B; Vajda, L, 1981) |
| "In a multicenter, single-blind, interpatient study, 103 outpatients with mild to moderate hypertension were given, after 2 weeks of placebo wash-out, 160 mg oxprenolol slow-release in fixed combination with chlorthalidone (20 mg per tablet) (SROC 160) once daily or conventional oxprenolol (80 mg) in fixed combination with chlorthalidone (10 mg per tablet) (COC 80) twice daily for 8 weeks." | 9.05 | A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension. ( Agabiti-Rosei, E; Buoninconti, R; Carotti, A; Fariello, R; Innocenti, P; Motolese, M; Muiesan, G; Toso, M; Valori, C, 1981) |
| "1 Indoramin, an alpha-adrenoreceptor blocking agent has been given as a third agent to patients with severe hypertension treated with adequate doses of a beta-adrenoceptor blocking drug and a thiazide diuretic." | 9.05 | Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension. ( Barritt, DW; Kettle, MA; Marshall, AJ, 1980) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 9.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 9.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "Sixteen patients with uncomplicated hypertension were studied in a double-blind within-patient trial comparing slow release oxprenolol (SRO) with conventional oxprenolol (CO)." | 9.04 | A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension. ( Havard, CW; Resnekov, EB, 1978) |
| "Two hundred and thirty-eight patients with essential hypertension from 39 general practice centres were treated in a double-blind trial with either oxprenolol 160 mg in a slow-release (SR) formulation with cyclopenthiazide 0,25 mg and potassium chloride 600 mg given once daily, or methyldopa 250 mg 3 times daily." | 9.04 | Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial. ( Levenstein, JH, 1978) |
| "Twenty-seven patients with mild to moderate arterial hypertension were treated "double-blind" with either atenolol of oxprenolol." | 9.04 | Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison. ( Brocklehurst, JE; Turner, AS; Watson, OF, 1979) |
| " The short term effects of hydrallazine, oxprenolol and oxprenolol plus hydrallazine were studied in five patients with essential hypertension." | 9.04 | Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol. ( Davies, IB; Rosenthal, T; Sever, PS, 1979) |
| "Fifty-three pregnant women with moderately severe hypertension were randomly allocated to treatment with methyldopa or oxprenolol." | 9.04 | Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. ( Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM, 1979) |
| "In a multicentre, double-blind, between-patient study the hypotensive effect of oxprenolol was investigated in 329 patients with mild to moderate hypertension." | 9.04 | Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study. ( Colombi, A; Motolese, M; Muiesan, G, 1975) |
| "Ten patients not maximally controlled on an oxprenolo/cyclopenthiazide regimen for moderately severe hypertension were treated in a double blind crossover trial with either hydrallazine (75-150 mg/day) or phentolamine (60-120 mg/day) or placebo in addition to their other therapy." | 9.04 | Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension. ( Kennedy, AC; McKillop, JH; Ward, DM; Winchester, JF, 1976) |
| "Nineteen patients receiving oxprenolol slow-release (SR) 160 mg (three patients) or 320 mg (16 patients) once daily for mild to moderate hypertension were treated with oxprenolol Oros 16/260 once daily for 3 weeks following a 2 week placebo wash-out period." | 7.67 | Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily. ( Allsopp, LF; Bolli, P; Bühler, FR; Cooper, GL; Frei, P; Glaus, L; Müller, FB; Ritz, R, 1985) |
| "The combination of prazosin (3-21 mg/day) and oxprenolol (60-360 mg/day) was used to treat 25 pregnant women with severe essential hypertension and 19 women with the hypertension-oedema-proteinuria syndrome." | 7.66 | Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. ( Hodge, JV; Lubbe, WF, 1981) |
| "Prazosin (Minipress; Pfizer), the first purely alpha-blocking antihypertensive agent, was used to treat 22 pregnant patients with moderately severe hypertension (diastolic blood pressure persistently above 95 mmHg at gestational ages ranging from 18 to 33 weeks)." | 7.66 | Prazosin and oxprenolol therapy in pregnancy hypertension. ( Davey, DA; Dommisse, J; Roos, PJ, 1983) |
| "Continuous intra-arterial blood pressure recording using the "Oxford" technique has been used to study the antihypertensive effects of oxprenolol taken three times daily in fully ambulatory patients with essential hypertension, outside hospital." | 7.66 | The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension. ( Altman, DG; Bala Subramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB, 1983) |
| "The long-term antihypertensive efficacy and tolerability of a fixed combination of oxprenolol 160 mg slow-release + chlortalidone 20 mg was studied in 40 out-patients with mild to moderate essential hypertension followed during one year with monthly clinical visits." | 7.66 | One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension. ( Ambroso, G; Lazzaretto, R; Masoni, A; Pirani, R; Tomasi, AM, 1981) |
| "In a multicentre double-blind study, 92 out-patients with mild to moderate hypertension who had a resting blood pressure greater than or equal to 160/100 mmHg after a two-weeks' placebo wash-out were treated for 6 weeks with a fixed combination of oxprenolol 80 mg + chlorthalidone 10 mg per tablet or chlorthalidone alone (1 tablet = 10 mg)." | 7.66 | Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension. ( Agabiti-Rosei, E; Carotti, A; Innocenti, P; Montervino, C; Motolese, M; Muiesan, G; Solinas, E; Toso, M, 1980) |
| "One hundred and two patients with essential hypertension, managed in hospital out-patient clinics in the United Kingdom on a drug regime of beta-receptor antagonist alone, or in combination with a diuretic were successfully transferred to once daily sustained release oxprenolol." | 7.66 | A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice. ( Forrest, WA, 1978) |
| "The effect of indomethacin on plasma renin activity (PRA), urinary aldosterone, 17 OH ketogenic steroids and plasma cortisol was studied in twenty-three patients with essential hypertension and compared in eleven patients to oxprenolol effect by 2 x 2 factorial trial." | 7.66 | The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension. ( Arzilli, F; Cavasinni, L; Pedrinelli, R; Poli, L; Salvetti, A; Sassano, P, 1978) |
| "The data from 40 patients with essential hypertension treated with oxprenolol alone have been used to analyse the falls of blood pressure and heart rate." | 7.65 | Beta blockade in essential hypertension: an analysis of response to oxprenolol. ( Barritt, DW; Marshall, AJ, 1977) |
| "Patients with moderate to severe hypertension were studied during a 12-week period, during which they were given a slow release formulation of oxprenolol once daily, in a dosage equal to their previous total daily dose of oxprenolol given in divided doses." | 7.65 | Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension. ( O'Brien, KP; Stephens, EJ, 1976) |
| " Patients with moderate to severe hypertension were studied during a 12 weeks period, while taking a slow-release formulation of oxprenolol once daily, in a dose equal to their previous total daily dose of oxprenolol given in divided doses." | 7.65 | Comparison of a slow-release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension. ( O'Brien, KP; Stephens, EJ, 1976) |
| "Oxprenolol is a beta-adrenergic blocker with intrinsic sympathomimetic activity." | 6.65 | Hemodynamic effects of oxprenolol and propranolol in hypertension. ( Franciosa, JA; Johnson, SM; Tobian, LJ, 1979) |
| "105 patients with previously untreated hypertension entered the trial and 72 completed it." | 6.65 | Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension. ( Nissinen, A; Tuomilehto, J, 1979) |
| "Oxprenolol or methyldopa were administered in double-blind fashion to 29 patients shown to be persistently hypertensive." | 6.64 | Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial. ( Barritt, DW; Heaton, S; Marshall, AJ, 1976) |
| "Prazosin appears to be a potent and appropriate third agent." | 6.64 | Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. ( Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J, 1977) |
| "Oxprenolol was the best tolerated drug, with only 5% of patients withdrawing due to side-effects compared to 13% on spironolacone and 29% on methyldopa." | 6.64 | Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension. ( Beilin, LJ; Ledingham, JG; Thomas, GW; Yeates, KM, 1976) |
| " The drugs could be given in a twice-daily dosage and had a much higher degree of patient acceptance." | 5.25 | Oxprenolol and hydrallazine in the treatment of hypertension. ( Freeman, JW; Knight, LW, 1975) |
| "Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials." | 5.22 | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. ( Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A, 2022) |
| "Sixty two black patients who had confirmed but untreated hypertension participated in a double blind clinical trial of the efficacy and tolerability of slow-release oxprenolol in a daily dose of 160 mg initially and 320 mg subsequently versus chlorthalidone 50 mg daily." | 5.06 | Efficacy and tolerability of long term oxprenolol and chlorthalidone singly and in combination in hypertensive blacks. ( Obel, AO, 1990) |
| "The paper deals with the study into the benefits of prazosin and trasicor used in arterial hypertension." | 5.06 | [Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor]. ( Damiĭonaĭtene, RA; Kuchinskene, ZZ; Rugenius, IuIu; Steponenene, RV; Vidugiris, AI, 1990) |
| "One hundred twenty black patients with mild to moderate essential hypertension participated in a double-blind placebo-controlled crossover study of the efficacy and tolerability of slow release oxprenolol versus chlorthalidone singly and in combination." | 5.06 | Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study. ( Obel, AO, 1989) |
| " Sixty middle-aged men with mild-to-moderate essential hypertension never previously treated were treated either with low-dose clonidine (n = 10), oxprenolol (n = 20), nitrendipine (n = 20) or enalapril (n = 10)." | 5.06 | Efficacy of four antihypertensive drugs (clonidine, enalapril, nitrendipine, oxprenolol) on stress blood pressure. ( Bähr, M; Langewitz, W; Rüddel, H; Schächinger, H; Schmieder, RE; Schulte, W, 1989) |
| "The effects of two oxprenolol oral osmotic (OROS) delivery systems on heart rate and blood pressure before and during recovery from exercise at a predetermined load were examined in twelve patients with hypertension previously responding to beta-blocker monotherapy." | 5.06 | Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension. ( Brodie, MJ; McInnes, GT, 1988) |
| " Middle aged male caucasian patients with hitherto untreated mild essential hypertension were given nitrendipine 10-20 mg per day, oxprenolol 160 mg per day or clonidine 75-300 micrograms per day until casual blood pressure was below 140/90 mmHg for at least three months." | 5.06 | Impact of antihypertensive therapy on blood pressure reactivity during mental stress. ( Langewitz, W; Rüddel, H; Schmieder, R; Schulte, W, 1988) |
| " Patients with uncomplicated essential hypertension were randomly allocated to one of two stepped-care treatment groups: enalapril 20 mg once-a-day, or placebo as the first step, followed when necessary by the successive addition of hydrochlorothiazide (25 and 50 mg), oxprenolol (160 and 320 mg) and dihydralazine (50 and 100 mg)." | 5.05 | A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension. ( Alhenc-Gelas, F; Amiot, AM; Chatellier, G; Corvol, P; Ménard, J; Sassano, P, 1984) |
| "The possibility of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy (8-18 months) with the slow-release (SR) formulation of oxprenolol (160-320 mg/day) was assessed in six patients with uncomplicated essential hypertension." | 5.05 | Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol. ( Amann, FW; Bolli, P; Bühler, FR; Burckhardt, D; Meier, M; Raeder, EA; Rogg, H, 1981) |
| "Twenty-five patients with moderate essential hypertension (standing diastolic blood pressure 100-125 mmHg, phase 5) completed a single-blind placebo-controlled cross-over study comparing four week periods of treatment with atenolol 100 mg, metoprolol 100 mg, metoprolol durules 200 mg, slow-release oxprenolol 160 mg, and slow-release oxprenolol 320 mg respectively." | 5.05 | Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. ( Hampton, JR; Wilcox, RG, 1981) |
| "The mechanisms of the changes in plasma lipids concentrations observed after beta-blockade were examined in 53 patients with hypertension receiving treatment with atenolol, metoprolol, propranolol, and oxprenolol in a randomised cross-over trial." | 5.05 | Adrenergic mechanisms in control of plasma lipid concentrations. ( Day, JL; Metcalfe, J; Simpson, CN, 1982) |
| "In 19 healthy men aged 50 with untreated mild essential hypertension (WHO group I classification) randomized into two groups, treatment (18 weeks) with oxprenolol (n = 10) lowered HDL cholesterol by 11." | 5.05 | The effect on HDL cholesterol of oxprenolol and atenolol. ( Eide, I; Eriksen, IL; Foss, OP; Holme, I; Kjeldsen, SE; Leren, P, 1982) |
| "In a randomized double-blind study of 175 patients with mild-to-moderate hypertension, oxprenolol hydrochloride (160-480 mg) given once daily was compared with the same drug given twice daily for efficacy, safety, and tolerability." | 5.05 | A double-blind study of oxprenolol once and twice daily in hypertensive patients. ( Friedman, B; Gerlings, E; Glazer, N; Gross, S; Lowney, C; Solomon, R, 1983) |
| "Thirty-two patients with moderate to severe essential hypertension whose supine diastolic blood pressure (SDBP) was greater than or equal to 95 mm Hg following 2 weeks' treatment with the optimal dosage of beta blocker-diuretic combination were randomly assigned to the addition of either captopril 25 mg or 50 mg b." | 5.05 | Efficacy of low-dose captopril given twice daily to patients with essential hypertension uncontrolled by a beta blocker plus thiazide diuretic. ( Agabiti-Rosei, E; Alicandri, C; Boni, E; Cinquegrana, A; Fariello, R; Montini, E; Muiesan, G; Muiesan, ML; Zaninelli, A, 1984) |
| "One hundred pregnant women with hypertension (defined as diastolic blood pressure at or above 95 mm Hg) were allocated at random to treatment with methyldopa or oxprenolol and were compared with nonhypertensive controls matched according to parity and gestation at delivery." | 5.05 | Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. ( De Swiet, M; Fayers, P; Fidler, J; Smith, V, 1983) |
| "In 19 men aged 50 with essential hypertension, 18 weeks' treatment with atenolol (n = 9) or oxprenolol (n = 10) increased supine plasma free dopamine concentrations by 78% (p less than 0." | 5.05 | Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension. ( Aakesson, I; Amundsen, R; Eide, I; Eriksen, IL; Kjeldsen, SE; Leren, P, 1983) |
| "Twelve students aged 21 to 39 years (mean age 26) with borderline hypertension underwent three 24 hours ambulatory recordings of blood pressure using an Avionics Pressurometer II device: the first recording under basic conditions, the second after taking placebo and the third after being treated for 3 days with a betablocker of long acting effect (oxprenolol R 160 mg) in a randomized study." | 5.05 | [Evaluation of a delayed-action beta blocker by 24-hour ambulatory recording of the arterial pressure]. ( Adamec, R; Barthélémy, JC; Campanini, C; Mérier, G, 1984) |
| "An open, randomized crossover study was carried out in 8 patients with accelerated hypertension to compare the antihypertensive efficacy of oxprenolol with that of propranolol." | 5.05 | Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension. ( Fernandez, PG; Galway, AB; Granter, S; Kim, BK; Sharma, JN; Zachariah, PK, 1982) |
| " To compare the effects of long-term administration of oxprenolol on hypertension and hemodynamics with the effects of propranolol, 20 patients with essential hypertension were divided in a double-blind random manner into two 10-patient groups and given placebo for 2 wk, followed by equipotent doses of oxprenolol or propranolol for 5 wk and by placebo for another 2 wk." | 5.05 | Antihypertensive and hemodynamic effects of oxprenolol versus propranolol. ( Aronow, WS; Easthope, JL; Ferlinz, J; Hughes, D; Siegel, J; Tobis, J, 1980) |
| "The effect of a vasodilator (hydralazine), a beta-blocker (oxprenolol) and also their combination, on essential arterial hypertension and plasma renin activity (PRA), was studied." | 5.05 | Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity. ( Siitonen, L, 1980) |
| "A double-blind crossover study was carried out to investigate the effects of cyclopenthiazide and oxprenolol on blood lipids in 20 previously untreated patients with mild to moderate hypertension." | 5.05 | Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study. ( Carruthers, M; Crisp, AJ; Ebbutt, AF; Hoffbrand, BI; Kennedy, PG, 1980) |
| "In a within-patient comparison of conventional oxprenolol administered twice daily with slow-release oxprenolol administered once daily in the treatment of hypertension, twenty patients previously responsive to beta-blockers took each formulation for 4 weeks, after wash-out periods off beta-blocker of 2 weeks' duration." | 5.05 | Once daily beta-blocker in hypertension--oxprenolol slow-release. ( Gordon, RD; Row, G; Rowe, WS; Strakosch, CR; Ziesak, M, 1981) |
| "48 patients with normal-renin essential hypertension were treated with prazosin alone or in combination with oxprenolol." | 5.05 | Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension. ( Farsang, C; Juhász, I; Kapocsi, J; Székács, B; Vajda, L, 1981) |
| "A double-blind, cross-over study in 16 patients with essential hypertension was carried out, to evaluate any possible interference by indomethacin, a known prostaglandin-synthetase inhibitor, with the antihypertensive effect of oxprenolol, a non-selective beta-adrenoceptor blocking agent." | 5.05 | Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. ( Arzilli, F; Beggi, P; Motolese, M; Pedrinelli, R; Salvetti, A, 1982) |
| "1 The effects of oxprenolol and propranolol on peripheral blood flow were compared in patients with mild and moderate essential hypertension." | 5.05 | The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients. ( Vandenburg, MJ, 1982) |
| "In a multicenter, single-blind, interpatient study, 103 outpatients with mild to moderate hypertension were given, after 2 weeks of placebo wash-out, 160 mg oxprenolol slow-release in fixed combination with chlorthalidone (20 mg per tablet) (SROC 160) once daily or conventional oxprenolol (80 mg) in fixed combination with chlorthalidone (10 mg per tablet) (COC 80) twice daily for 8 weeks." | 5.05 | A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension. ( Agabiti-Rosei, E; Buoninconti, R; Carotti, A; Fariello, R; Innocenti, P; Motolese, M; Muiesan, G; Toso, M; Valori, C, 1981) |
| "The effects of oxprenolol on blood pressure levels, pulmonary ventilatory function, myocardial contractility and myocardial oxygen consumption are described in 66 patients with essential hypertension and no clinical evidence of obstructive lung disease of heart failure." | 5.05 | Effect of oxprenolol on blood pressure, pulmonary ventilatory function and myocardial contractility in hypertensive patients. ( Barzilay, J; Schlesinger, Z, 1980) |
| "1 Indoramin, an alpha-adrenoreceptor blocking agent has been given as a third agent to patients with severe hypertension treated with adequate doses of a beta-adrenoceptor blocking drug and a thiazide diuretic." | 5.05 | Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension. ( Barritt, DW; Kettle, MA; Marshall, AJ, 1980) |
| " Thirty untreated male patients with WHO stage I essential hypertension (mean age 43 +/- 6 years) were randomly allocated to oxprenolol or nitrendipine groups." | 5.05 | Predictors of blood pressure increases after withdrawal of antihypertensive therapy. ( Neus, H; Neus, J; Rüddel, H; Schmieder, RE; von Eiff, AW, 1985) |
| "Single doses of bucindolol 50, 100 and 200 mg were compared to placebo and single doses of oxprenolol 40, 80 and 160 mg in seven patients with mild hypertension, in a double-blind randomized study." | 5.05 | A comparison of single doses of bucindolol and oxprenolol in hypertensive patients. ( Jamieson, M; Petrie, JC; Robb, OJ; Verschueren, J; Webster, J, 1985) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 5.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| "Twenty-eight previously untreated patients with essential hypertension were included in a randomized double-blind cross-over study comparing the results of treatment with the established combination of a thiazide and methyldopa (regimen A) with the combination of a beta-receptor blocker and hydralazine (regimen B)." | 5.04 | Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine. ( Hansen, M; Hansen, OP; Lindholm, J, 1977) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 5.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "Sixteen patients with uncomplicated hypertension were studied in a double-blind within-patient trial comparing slow release oxprenolol (SRO) with conventional oxprenolol (CO)." | 5.04 | A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension. ( Havard, CW; Resnekov, EB, 1978) |
| "Two hundred and thirty-eight patients with essential hypertension from 39 general practice centres were treated in a double-blind trial with either oxprenolol 160 mg in a slow-release (SR) formulation with cyclopenthiazide 0,25 mg and potassium chloride 600 mg given once daily, or methyldopa 250 mg 3 times daily." | 5.04 | Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial. ( Levenstein, JH, 1978) |
| "Twenty-seven patients with mild to moderate arterial hypertension were treated "double-blind" with either atenolol of oxprenolol." | 5.04 | Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison. ( Brocklehurst, JE; Turner, AS; Watson, OF, 1979) |
| " The short term effects of hydrallazine, oxprenolol and oxprenolol plus hydrallazine were studied in five patients with essential hypertension." | 5.04 | Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol. ( Davies, IB; Rosenthal, T; Sever, PS, 1979) |
| "Fifty-three pregnant women with moderately severe hypertension were randomly allocated to treatment with methyldopa or oxprenolol." | 5.04 | Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. ( Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM, 1979) |
| "In a multicentre, double-blind, between-patient study the hypotensive effect of oxprenolol was investigated in 329 patients with mild to moderate hypertension." | 5.04 | Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study. ( Colombi, A; Motolese, M; Muiesan, G, 1975) |
| "Ten patients not maximally controlled on an oxprenolo/cyclopenthiazide regimen for moderately severe hypertension were treated in a double blind crossover trial with either hydrallazine (75-150 mg/day) or phentolamine (60-120 mg/day) or placebo in addition to their other therapy." | 5.04 | Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension. ( Kennedy, AC; McKillop, JH; Ward, DM; Winchester, JF, 1976) |
| " In the first part of the eighties two prospective multi-center randomised trials were conducted to determine the effect of captopril in comparison to methyldopa or an unselective beta-blocker on the quality of life in patients with mild to moderate hypertension (Hill et al." | 4.78 | ACE-inhibitors and quality of life. ( Herlitz, H, 1990) |
| "A previously normal 58-year-old woman developed a widespread psoriatic rash and asymmetrical peripheral polyarthritis a week after beginning treatment with oxprenolol for hypertension." | 3.67 | Acute psoriatric arthropathy precipitated by oxprenolol. ( Macfarlane, DG; Settas, L, 1984) |
| "Intra-arterial 24 hour blood pressure (BP) recording (OXFORD MEDILOG) was carried out in 10 patients with essential hypertension, 6 males and 4 females, aged between 41 and 58 years, 3 at WHO stage 1 and 7 at stage 2, in basal conditions and after 6 weeks of treatment with a fixed combination of 160 mg of slow-release oxprenolol and 20 mg of chlorthalidone per tablet (tb)." | 3.67 | [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day]. ( Agabiti-Rosei, E; Alicandri, C; Boni, E; Fariello, R; Montini, E; Motolese, M; Muiesan, G; Zaninelli, A, 1984) |
| "Six elderly patients with established hypertension and six young healthy subjects were studied after 8 days of treatment with atenolol 50 mg day-1, metoprolol 50 mg day-1, oxprenolol 80 mg day-1 and propranolol 80 mg day-1." | 3.67 | A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects. ( Hawksworth, GM; Petrie, JC; Rigby, JW; Scott, AK, 1985) |
| "The effect of long-term treatment with propranolol (45 patients), trasicor (15), visken (23) and combinations thereof with phentolamine and labetalol (12) on submaximum exercise tolerance was studied in patients with second-stage essential hypertension." | 3.67 | [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension]. ( Smirnov, GB, 1986) |
| "As part of the Veterans Administration cooperative studies on antihypertensive agents, systolic time intervals (STIs) were recorded before and after 2 or 4 weeks of treatment with hydrochlorothiazide (HCTZ) alone in 320 asymptomatic patients with mild to moderate hypertension." | 3.67 | Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents. ( Freis, ED; Kyle, MC, 1985) |
| "Nineteen patients receiving oxprenolol slow-release (SR) 160 mg (three patients) or 320 mg (16 patients) once daily for mild to moderate hypertension were treated with oxprenolol Oros 16/260 once daily for 3 weeks following a 2 week placebo wash-out period." | 3.67 | Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily. ( Allsopp, LF; Bolli, P; Bühler, FR; Cooper, GL; Frei, P; Glaus, L; Müller, FB; Ritz, R, 1985) |
| "The combination of prazosin (3-21 mg/day) and oxprenolol (60-360 mg/day) was used to treat 25 pregnant women with severe essential hypertension and 19 women with the hypertension-oedema-proteinuria syndrome." | 3.66 | Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. ( Hodge, JV; Lubbe, WF, 1981) |
| " Propranolol, acebutolol and practolol, at a daily dose of 50 mg/kg, prevented the occurrence of hypertension, not only during the 4 weeks of treatment, but also during 6,9 and 11 weeks respectively after cessation of treatment." | 3.66 | Variability in the preventive action of the B-blockers on genetic hypertension in the rat. ( Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP, 1980) |
| "The interrelationship between PRA, urinary aldosterone excretion, and blood pressure was studied in 11 patients with essential hypertension while receiving a diuretic (1st week) and subsequently a diuretic + oxprenolol (2nd week)." | 3.66 | The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics. ( Pedrinelli, R; Salvetti, A; Simonini, N, 1982) |
| "Prazosin (Minipress; Pfizer), the first purely alpha-blocking antihypertensive agent, was used to treat 22 pregnant patients with moderately severe hypertension (diastolic blood pressure persistently above 95 mmHg at gestational ages ranging from 18 to 33 weeks)." | 3.66 | Prazosin and oxprenolol therapy in pregnancy hypertension. ( Davey, DA; Dommisse, J; Roos, PJ, 1983) |
| "Continuous intra-arterial blood pressure recording using the "Oxford" technique has been used to study the antihypertensive effects of oxprenolol taken three times daily in fully ambulatory patients with essential hypertension, outside hospital." | 3.66 | The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension. ( Altman, DG; Bala Subramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB, 1983) |
| "The long-term antihypertensive efficacy and tolerability of a fixed combination of oxprenolol 160 mg slow-release + chlortalidone 20 mg was studied in 40 out-patients with mild to moderate essential hypertension followed during one year with monthly clinical visits." | 3.66 | One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension. ( Ambroso, G; Lazzaretto, R; Masoni, A; Pirani, R; Tomasi, AM, 1981) |
| "In a multicentre double-blind study, 92 out-patients with mild to moderate hypertension who had a resting blood pressure greater than or equal to 160/100 mmHg after a two-weeks' placebo wash-out were treated for 6 weeks with a fixed combination of oxprenolol 80 mg + chlorthalidone 10 mg per tablet or chlorthalidone alone (1 tablet = 10 mg)." | 3.66 | Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension. ( Agabiti-Rosei, E; Carotti, A; Innocenti, P; Montervino, C; Motolese, M; Muiesan, G; Solinas, E; Toso, M, 1980) |
| " Reversal of this intrauterine growth retardation was achieved in 19 patients by treatment of hypertension with oxprenolol." | 3.66 | Improvement in foetal growth with treatment of maternal hypertension in pregnancy. ( Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM, 1978) |
| "A multicentre, open study of general practice patients with essential hypertension who were currently being treated with oxprenolol and cyclopenthiazide was undertaken in which the patients were transferred to Trasidrex for 12 weeks." | 3.66 | A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K. ( Ebbutt, AF; Elsdon-Dew, RW, 1979) |
| "One hundred and two patients with essential hypertension, managed in hospital out-patient clinics in the United Kingdom on a drug regime of beta-receptor antagonist alone, or in combination with a diuretic were successfully transferred to once daily sustained release oxprenolol." | 3.66 | A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice. ( Forrest, WA, 1978) |
| "Minoxidil-induced sequential changes in plasma renin activity, urinary aldosterone and norepinephrine excretion were assessed in 11 patients with severe hypertension receiving propranolol or oxprenolol, chlorthalidone and spironolactone." | 3.66 | [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers]. ( Brunner, HR; Ferguson, RK; Gavras, H; Jaeger, P; Jéquier, E; Turini, GA, 1978) |
| "Sixty-two patients with hypertension who were treated with a free combination of Slow Trasicor or Trasicor and Navidrex K were transferred to a fixed combination tablet, Trasidrex (slow oxprenolol 160 mg + cyclopenthiazide 0." | 3.66 | Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice. ( Ebbut, AF; Elsdon-Dew, RW; Murphy, JE, 1978) |
| "The effect of indomethacin on plasma renin activity (PRA), urinary aldosterone, 17 OH ketogenic steroids and plasma cortisol was studied in twenty-three patients with essential hypertension and compared in eleven patients to oxprenolol effect by 2 x 2 factorial trial." | 3.66 | The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension. ( Arzilli, F; Cavasinni, L; Pedrinelli, R; Poli, L; Salvetti, A; Sassano, P, 1978) |
| "The effects of beta-adrenergic blockade, using oxprenolol, were studied in plasma renin activity, urinary sodium excretion and blood pressure in ten normal subjects and in 120 patients with essential and renovascular hypertension." | 3.65 | The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension. ( Arzilli, F; Pedrinelli, R; Poli, L; Salvetti, A; Sassano, P, 1977) |
| "The data from 40 patients with essential hypertension treated with oxprenolol alone have been used to analyse the falls of blood pressure and heart rate." | 3.65 | Beta blockade in essential hypertension: an analysis of response to oxprenolol. ( Barritt, DW; Marshall, AJ, 1977) |
| "Patients with moderate to severe hypertension were studied during a 12-week period, during which they were given a slow release formulation of oxprenolol once daily, in a dosage equal to their previous total daily dose of oxprenolol given in divided doses." | 3.65 | Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension. ( O'Brien, KP; Stephens, EJ, 1976) |
| " Patients with moderate to severe hypertension were studied during a 12 weeks period, while taking a slow-release formulation of oxprenolol once daily, in a dose equal to their previous total daily dose of oxprenolol given in divided doses." | 3.65 | Comparison of a slow-release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension. ( O'Brien, KP; Stephens, EJ, 1976) |
| "This paper presents experience with the treatment of mild to moderate hypertension by means of a thiazide diuretic (cyclopenthiazide), a small dose of a beta adrenergic blocking agent (oxprenolol) and progressively increasing doses of a vasodilator (hydrallazine)." | 3.65 | Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension. ( Goble, AJ, 1975) |
| "Twenty-three out-patients with mild or moderate essential hypertension have been treated with a combination of hydralazine (37." | 3.65 | Acetylator phenotype and the antihypertensive response to hydralazine. ( Jounela, AJ; Mattila, MJ; Pasanen, M, 1975) |
| "This study was designed to obtain information under general practice conditions on the efficacy and tolerability of a fixed combination of the beta-blocking agent oxprenolol 80 mg (Trasicor 80) and hydrochlorothiazide + KCl (Esidrex-K) in the treatment of moderate essential hypertension." | 3.65 | [Treatment of essential hypertension with Transicor 80 and Esidrex K under medical practice conditions]. ( Mauracher, EH; Rivier, JL, 1976) |
| "Treatment with labetalol, on the other hand, led to an improvement in respiratory function." | 2.66 | Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease. ( Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O, 1986) |
| "Captopril was associated with a significantly (P less than 0." | 2.66 | Angiotensin converting enzyme inhibitors and quality of life: the European trial. ( Bulpitt, CJ; Fletcher, AE; Hill, JF, 1985) |
| "Oxprenolol (OX) is a nonselective, beta-adrenergic blocking agent with intrinsic sympathomimetic activity." | 2.65 | Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical trial. ( Friedman, BA; Glazer, N; Gray, JM; Gross, S; Hla, KM; Materson, BJ; Neidorf, BS, 1983) |
| "Oxprenolol was well tolerated in the elderly; it produced a low incidence of typical beta-blocker side effects even when given in a once-daily regimen." | 2.65 | Clinical responses to oxprenolol in the elderly. ( Ellis, RA, 1983) |
| " The results from this study suggest that these compounds in their standard dosage range are useful and safe antihypertensive agents in older patients." | 2.65 | The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination. ( Forrest, WA, 1981) |
| "Oxprenolol was administered in combination with clortalidone in group B and with phentolamine in group C." | 2.65 | [Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension]. ( D'Agnolo, B; Lupinc, V; Minutillo, S, 1979) |
| "Oxprenolol is a beta-adrenergic blocker with intrinsic sympathomimetic activity." | 2.65 | Hemodynamic effects of oxprenolol and propranolol in hypertension. ( Franciosa, JA; Johnson, SM; Tobian, LJ, 1979) |
| " However, patient compliance might be considerably improved with the once-daily dosage schedule of the fixed combination." | 2.65 | Antihypertensive effect of oxprenolol and chlorthalidone in fixed combination, given once daily. ( Buoninconti, R; Motolese, M; Rubegni, M, 1979) |
| "105 patients with previously untreated hypertension entered the trial and 72 completed it." | 2.65 | Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension. ( Nissinen, A; Tuomilehto, J, 1979) |
| "Oxprenolol was given as the first drug to Group 1, and cyclopenthiazide as the first drug to Group 2." | 2.64 | Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment. ( Davies, R; Payne, NN; Slater, JD, 1976) |
| " Drug dosage was selected to be proportionate to beta-adrenoreceptor-blocking potency; d-propranolol dosage equalled approximately that of racemic propranolol." | 2.64 | The antihypertensive action of several beta-adrenoreceptor-blocking drugs. ( Waal-Manning, HJ, 1976) |
| "Oxprenolol or methyldopa were administered in double-blind fashion to 29 patients shown to be persistently hypertensive." | 2.64 | Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial. ( Barritt, DW; Heaton, S; Marshall, AJ, 1976) |
| "Prazosin appears to be a potent and appropriate third agent." | 2.64 | Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. ( Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J, 1977) |
| "Phentolamine has no clinically useful anti-hypertensive effect in conjunction with beta-blockers in patients with essential hypertension." | 2.64 | The transient anti-hypertensive effect of phentolamine in patients receiving beta-blocker treatment. ( Dawson, A; Johnson, BF; Smith, I, 1977) |
| "With propranolol, findings were 138 +/- 3/106 +/- 2 to 123 +/- 3/89 +/- 3; in 7 of 12 to less than 91 mm Hg and from 91 to 95 in 4 subjects." | 2.64 | Antihypertensive effects of oxprenolol and propranolol. ( Materson, BJ; Michael, UF; Oster, JR; Perez-Stable, EC, 1976) |
| "Oxprenolol was the best tolerated drug, with only 5% of patients withdrawing due to side-effects compared to 13% on spironolacone and 29% on methyldopa." | 2.64 | Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension. ( Beilin, LJ; Ledingham, JG; Thomas, GW; Yeates, KM, 1976) |
| "Oxprenolol is a potent noncardioselective beta-adrenoceptor blocking drug with partial agonist activity of proved efficacy and high tolerability in patients at risk of various cardiovascular disease syndromes." | 2.36 | Oxprenolol in clinical practice. ( Taylor, SH, 1983) |
| "Oxprenolol treatment did not modify the blood pressure levels in the renal hypertensive rats nor in the spontaneously hypertensive turkeys." | 1.28 | Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension. ( Dal Palù, C; Pauletto, P; Pessina, AC; Scannapieco, G; Vescovo, G, 1990) |
| "When prazosin was added to a beta-blocker/diuretic regimen, there was a further and statistically significant (p less than 0." | 1.27 | Effect of prazosin on blood pressure and plasma lipids in patients receiving a beta-blocker and diuretic regimen. ( Mauersberger, H, 1984) |
| " PRA activity was significantly and markedly reduced by both bunolol and metoprolol shortly after dosing at a time when HR was significantly reduced but MBP was not." | 1.27 | Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. ( Antonaccio, MJ; DeForrest, JM; High, J; Sybertz, E, 1986) |
| "To evaluate the effects of the chronic administration of the fixed combination slow-release, oxprenolol 160 mg and chlorthalidone 20 mg on left ventricular hypertrophy, ten hypertensive out-patients, with left ventricular hypertrophy documented by left ventricular mass index (LVMI) greater than 130 g/m2, were studied." | 1.27 | Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study. ( Alberti, D; Bertoni, T; De Ambroggi, L; Francucci, BM; Peloso, A, 1988) |
| "Hypertension is characterized by high levels of circulating and tissue catecholamines; atherosclerosis affects mainly the aorto-iliac tract." | 1.27 | Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenolol. ( Angelini, A; Dal Palù, C; Mazzucato, A; Pagnan, A; Pauletto, P; Pessina, AC; Scannapieco, G; Semplicini, A; Thiene, G; Vescovo, G, 1985) |
| " Results obtained show that the fixed combination oxprenolol 80 mg plus chlorthalidone 10 mg can be safely administered also in the elderly hypertensive patients, without risk of cardiovascular complications, allowing satisfactory blood pressure control, with a simple dosage schedule, thus improving patient compliance to the therapy." | 1.26 | [Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients]. ( Andreoni, A; Paciaroni, E; Quattrini, L; Saccomanno, G, 1980) |
| "Oxprenolol was rapidly absorbed from the gastrointestinal tract and was quickly eliminated from plasma." | 1.26 | Disposition of oxprenolol in spontaneously hypertensive rats as determined by an enzyme immunoassay. ( Kawashima, K, 1981) |
| "Labetalol, which is a combined alpha- and beta-blocking agent, reduces mean blood pressure levels at all times." | 1.26 | Effects of treatment on circadian rhythms of blood pressure. ( Balasubramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB, 1981) |
| "Acebutolol was compared with oxprenolol in the treatment of 17 CVD patients with hypertension of long standing, 14 of whom had cardiac abnormalities and 16 retired abnormalities." | 1.26 | Comparative study of acebutolol and oxprenolol in the management of hypertensive cerebrovascular diseases (CVD) patients. ( Almatsier, M; Ranakusuma, TA; Soemargo, S; Tobing, SM, 1981) |
| "Propranolol did not cause this pressor effect in prehypertensive (seven week old) SHRs." | 1.26 | Beta-adrenergic receptor blocking drugs in spontaneous hypertension. ( Levy, JV, 1976) |
| " As 77 percent of the patients considered the once daily dose in a calendar pack to be helpful, simplification of dosage was thought to be an important factor in improving patient compliance, which resulted in better blood pressure control without an increase in unwanted effects." | 1.26 | Once daily administration of a beta-blocker in hypertension. ( Duncan, TD; Watt, M, 1978) |
| "3." | 1.26 | Blood pressure circadian rhythm in essential hypertension. ( Balasubramanian, V; Mann, S; Millar Craig, MW; Raftery, EB, 1978) |
| " The drugs could be given in a twice-daily dosage and had a much higher degree of patient acceptance." | 1.25 | Oxprenolol and hydrallazine in the treatment of hypertension. ( Freeman, JW; Knight, LW, 1975) |
| " From the third week of treatment onwards, the Esidrix dosage was maintained; the dosage of Trasicor 80 was either maintained, increased, or later decreased, according to the results obtained." | 1.25 | [Ambulatory treatment of arterial hypertension urinary the new combination "saluretic and beta-sympatholytic"]. ( Dannhorn, R; Müller, AA, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 289 (96.01) | 18.7374 |
| 1990's | 10 (3.32) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (0.33) | 24.3611 |
| 2020's | 1 (0.33) | 2.80 |
| Authors | Studies |
|---|---|
| Esler, M | 1 |
| Kjeldsen, SE | 4 |
| Pathak, A | 1 |
| Grassi, G | 1 |
| Kreutz, R | 1 |
| Mancia, G | 2 |
| Zhang, Y | 1 |
| Sun, N | 1 |
| Jiang, X | 1 |
| Xi, Y | 1 |
| Rüddel, H | 8 |
| Schmieder, R | 3 |
| Langewitz, W | 5 |
| Neus, J | 3 |
| Wagner, O | 2 |
| von Eiff, AW | 4 |
| Sassano, P | 3 |
| Chatellier, G | 1 |
| Amiot, AM | 1 |
| Alhenc-Gelas, F | 1 |
| Corvol, P | 3 |
| Ménard, J | 3 |
| Forrest, WA | 12 |
| Del Guercio, R | 2 |
| Gentile, S | 2 |
| Saponara, A | 2 |
| De Buono, AF | 2 |
| Paciaroni, E | 1 |
| Quattrini, L | 1 |
| Saccomanno, G | 1 |
| Andreoni, A | 1 |
| Lubbe, WF | 3 |
| Hodge, JV | 2 |
| Bolli, P | 3 |
| Bühler, FR | 7 |
| Raeder, EA | 1 |
| Amann, FW | 1 |
| Meier, M | 1 |
| Rogg, H | 1 |
| Burckhardt, D | 1 |
| Wilcox, RG | 1 |
| Hampton, JR | 1 |
| de Clavière, M | 1 |
| Heyndrickx, JP | 1 |
| Brotelle, R | 1 |
| Colot, M | 1 |
| Day, JL | 1 |
| Metcalfe, J | 1 |
| Simpson, CN | 1 |
| Eide, I | 3 |
| Leren, P | 3 |
| Foss, OP | 1 |
| Holme, I | 1 |
| Eriksen, IL | 2 |
| Tsukiyama, H | 1 |
| Otsuka, K | 1 |
| Horii, M | 1 |
| Yoshii, Y | 1 |
| Hatori, Y | 1 |
| Nakamura, Y | 1 |
| Nemoto, E | 1 |
| Yamato, T | 1 |
| Sakai, T | 1 |
| Yamamoto, Y | 1 |
| Velikanov, KA | 1 |
| Shvets, VD | 1 |
| Ostman, J | 1 |
| Taylor, SH | 7 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Sandström, B | 1 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Freis, ED | 2 |
| Rubin, PC | 1 |
| Idikio, H | 1 |
| Fernandez, PG | 2 |
| Triggle, CR | 1 |
| Kim, BK | 2 |
| Macfarlane, DG | 1 |
| Settas, L | 1 |
| Materson, BJ | 3 |
| Friedman, BA | 1 |
| Hla, KM | 1 |
| Neidorf, BS | 1 |
| Gray, JM | 2 |
| Glazer, N | 2 |
| Gross, S | 3 |
| Friedman, B | 2 |
| Gerlings, E | 1 |
| Lowney, C | 1 |
| Solomon, R | 1 |
| Scannapieco, G | 3 |
| Pauletto, P | 3 |
| Semplicini, A | 2 |
| Dario, C | 1 |
| Vescovo, G | 3 |
| Mazzucato, A | 2 |
| Angelini, A | 2 |
| Pessina, AC | 3 |
| Krönig, B | 1 |
| Wendt, G | 1 |
| Levit, SA | 1 |
| Ellis, RA | 1 |
| Schlesinger, Z | 2 |
| Ravid, M | 2 |
| Meshulam, R | 1 |
| Skjøtø, J | 1 |
| Aakesson, I | 2 |
| Os, I | 1 |
| Borghi, C | 2 |
| Pallavini, G | 1 |
| Comi, D | 2 |
| Grillo, G | 1 |
| Lombardo, M | 2 |
| Mantero, O | 2 |
| Minetti, L | 2 |
| Selvini, A | 2 |
| Suppa, G | 2 |
| Muiesan, G | 7 |
| Alicandri, C | 3 |
| Agabiti-Rosei, E | 4 |
| Fariello, R | 3 |
| Montini, E | 2 |
| Muiesan, ML | 1 |
| Boni, E | 2 |
| Cinquegrana, A | 1 |
| Zaninelli, A | 2 |
| Costa, FV | 2 |
| Ambrosioni, E | 2 |
| Cybulska, I | 3 |
| Sznajderman, M | 3 |
| Fidler, J | 2 |
| Smith, V | 2 |
| Fayers, P | 1 |
| De Swiet, M | 2 |
| Shanks, RG | 1 |
| Sioufi, A | 1 |
| Hillion, D | 1 |
| Lumbroso, P | 1 |
| Wainer, R | 1 |
| Olivier-Martin, M | 1 |
| Schoeller, JP | 1 |
| Colussi, D | 1 |
| Leroux, F | 1 |
| Mangoni, P | 1 |
| Pollavini, G | 1 |
| Grillo, C | 1 |
| O'Boyle, CP | 2 |
| Fitzgerald, D | 1 |
| Kelly, JG | 1 |
| O'Malley, K | 2 |
| O'Brien, ET | 2 |
| Rossi, A | 1 |
| Ziacchi, V | 1 |
| Fracalossi, C | 1 |
| Marino, A | 1 |
| Lomanto, B | 1 |
| Amundsen, R | 1 |
| Karachalios, GN | 1 |
| Campanini, C | 1 |
| Adamec, R | 1 |
| Barthélémy, JC | 1 |
| Mérier, G | 1 |
| Mauersberger, H | 1 |
| Motolese, M | 9 |
| Hilgert, A | 1 |
| Horch, G | 1 |
| Sharma, JN | 1 |
| Galway, AB | 1 |
| Granter, S | 1 |
| Zachariah, PK | 1 |
| Brym, E | 1 |
| Salvetti, A | 6 |
| Pedrinelli, R | 5 |
| Simonini, N | 1 |
| Gallery, ED | 5 |
| Burke, T | 1 |
| Hausen, T | 1 |
| Dommisse, J | 1 |
| Davey, DA | 1 |
| Roos, PJ | 1 |
| Millar-Craig, MW | 5 |
| Mann, S | 6 |
| Bala Subramanian, V | 1 |
| Altman, DG | 2 |
| Raftery, EB | 7 |
| Zacest, R | 1 |
| Barrow, CG | 1 |
| O'Halloran, MW | 1 |
| Wilson, LL | 1 |
| Kellaway, GS | 1 |
| Simons, LA | 1 |
| England, JD | 1 |
| Balasubramaniam, S | 1 |
| Viles, L | 1 |
| Ferlinz, J | 2 |
| Easthope, JL | 2 |
| Hughes, D | 2 |
| Siegel, J | 2 |
| Tobis, J | 2 |
| Aronow, WS | 2 |
| Siitonen, L | 2 |
| Franciosa, JA | 2 |
| Johnson, SM | 2 |
| Tobian, LJ | 2 |
| Petrie, JC | 3 |
| Jeffers, TA | 1 |
| Robb, OJ | 2 |
| Scott, AK | 2 |
| Webster, J | 2 |
| Montanaro, D | 1 |
| Antonello, A | 1 |
| Baggio, B | 1 |
| Finotti, P | 1 |
| Melacini, P | 1 |
| Ferrari, M | 1 |
| Crisp, AJ | 1 |
| Kennedy, PG | 1 |
| Hoffbrand, BI | 1 |
| Ebbutt, AF | 2 |
| Carruthers, M | 1 |
| Gruppillo, P | 1 |
| Tomasi, AM | 2 |
| Masoni, A | 2 |
| Finzi, C | 1 |
| Albanesi Filho, FM | 1 |
| Benchimol, AB | 1 |
| Gerc, V | 1 |
| Numić, N | 1 |
| Gordon, RD | 1 |
| Ziesak, M | 1 |
| Rowe, WS | 1 |
| Strakosch, CR | 1 |
| Row, G | 1 |
| Levenstein, JH | 3 |
| Nomura, G | 1 |
| Arai, S | 1 |
| Maekawa, M | 1 |
| Ohta, H | 1 |
| Takabatake, T | 1 |
| Farsang, C | 1 |
| Juhász, I | 1 |
| Kapocsi, J | 1 |
| Vajda, L | 1 |
| Székács, B | 1 |
| Baronchelli, A | 1 |
| Agosta, R | 1 |
| Verdecchia, P | 1 |
| Bichisao, E | 1 |
| Elsdon-Dew, RW | 3 |
| Holden, E | 1 |
| Kawashima, K | 2 |
| Benfield, GF | 1 |
| Hunter, KR | 1 |
| Arzilli, F | 4 |
| Beggi, P | 1 |
| Comerford, MB | 1 |
| Besterman, EM | 1 |
| Vandenburg, MJ | 1 |
| Caimi, G | 1 |
| Frazzetta, F | 1 |
| Capobianco, D | 1 |
| Catania, A | 1 |
| Francavilla, G | 1 |
| Sarno, A | 1 |
| Moscovici, H | 1 |
| Yasbeck Júnior, P | 1 |
| Fadul Neto, J | 1 |
| Kelly, J | 1 |
| Zampaglione, G | 1 |
| Ferrari, O | 1 |
| Bianchi, C | 1 |
| Bonifazi, C | 1 |
| Coppetti, S | 1 |
| Costanza, G | 1 |
| Lanzarini, L | 1 |
| Ricevuti, A | 1 |
| Rinaldo, R | 1 |
| Rizzi, GM | 1 |
| Tavecchi, L | 1 |
| Ziletti, G | 1 |
| Distante, S | 1 |
| Ballantyne, D | 1 |
| Ballantyne, FC | 1 |
| Balasubramanian, V | 5 |
| Cashman, P | 1 |
| Giec, L | 1 |
| Sledziński, Z | 1 |
| Trusz-Gluza, M | 1 |
| Nieszporek, T | 1 |
| Hübner, D | 1 |
| Mleczko, Z | 1 |
| Olwiński, M | 1 |
| Buoninconti, R | 2 |
| Carotti, A | 2 |
| Innocenti, P | 2 |
| Toso, M | 2 |
| Valori, C | 3 |
| Ranakusuma, TA | 1 |
| Tobing, SM | 1 |
| Almatsier, M | 1 |
| Soemargo, S | 1 |
| Pirani, R | 1 |
| Lazzaretto, R | 1 |
| Ambroso, G | 2 |
| Marata, AM | 1 |
| Montebugnoli, L | 1 |
| Rosati, G | 1 |
| Magnani, B | 1 |
| Jones, DH | 1 |
| Daniel, J | 1 |
| Hamilton, CA | 1 |
| Reid, JL | 1 |
| Barzilay, J | 1 |
| Montervino, C | 1 |
| Solinas, E | 1 |
| García Sacristán, A | 1 |
| Smith, GL | 1 |
| Feely, J | 1 |
| Marshall, AJ | 6 |
| Kettle, MA | 1 |
| Barritt, DW | 7 |
| Deibert, K | 1 |
| Larkin, H | 1 |
| Hunyor, SN | 3 |
| Gyory, AZ | 4 |
| Boyce, ES | 1 |
| Sau, F | 3 |
| Seguro, C | 3 |
| Pargentino, E | 1 |
| Davies, R | 1 |
| Payne, NN | 1 |
| Slater, JD | 1 |
| Turner, R | 1 |
| White, P | 1 |
| Benton, F | 1 |
| Roberts, CJ | 1 |
| Davidson, C | 1 |
| Thadani, U | 1 |
| Singleton, W | 1 |
| Waal-Manning, HJ | 2 |
| Levy, JV | 1 |
| Talbot, S | 1 |
| Lütold, BE | 3 |
| Hata, S | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Harry, JD | 1 |
| Knapp, MF | 1 |
| Linden, RJ | 1 |
| Stoker, JB | 1 |
| Newcombe, C | 1 |
| Turner, P | 1 |
| Hitzenberger, G | 1 |
| Prichard, BN | 1 |
| Minutillo, S | 1 |
| Lupinc, V | 1 |
| D'Agnolo, B | 1 |
| Heaton, S | 1 |
| Jackson, G | 1 |
| Pierscianowski, TA | 1 |
| Mahon, W | 1 |
| Condon, J | 1 |
| Pocock, J | 1 |
| Heaton, ST | 1 |
| Mertz, DP | 1 |
| Kendall, MJ | 1 |
| Quarterman, CP | 1 |
| Bishop, H | 1 |
| Schneider, RE | 1 |
| Plouin, PF | 3 |
| Gouin, F | 1 |
| Milliez, P | 1 |
| Meurer, KA | 1 |
| Frisch, P | 1 |
| Burkart, F | 2 |
| Küng, M | 2 |
| Marbet, G | 1 |
| Pfisterer, M | 1 |
| Watt, M | 1 |
| Duncan, TD | 1 |
| Spears, GF | 1 |
| Saunders, DM | 2 |
| Millar Craig, MW | 1 |
| Kalowski, S | 1 |
| Hua, AS | 1 |
| Whitworth, JA | 1 |
| Kincaid-Smith, P | 1 |
| Gyntelberg, F | 1 |
| Jacobsen, K | 1 |
| Martlev, A | 1 |
| Backer, P | 1 |
| Rowlands, G | 1 |
| McConachie, NA | 1 |
| Currie, WJ | 1 |
| Hansen, M | 1 |
| Hansen, OP | 1 |
| Lindholm, J | 1 |
| Dawson, A | 1 |
| Smith, I | 1 |
| Johnson, BF | 3 |
| Perks, WH | 1 |
| Chatterjee, SS | 1 |
| Croxson, RS | 1 |
| Cruickshank, JM | 1 |
| Resnekov, EB | 1 |
| Havard, CW | 1 |
| Gavras, I | 1 |
| Gavras, H | 2 |
| Sullivan, PC | 1 |
| Tifft, CP | 1 |
| Chobanian, AV | 1 |
| Brunner, HR | 2 |
| Tuomilehto, J | 2 |
| Turner, AS | 1 |
| Watson, OF | 1 |
| Brocklehurst, JE | 1 |
| Rubegni, M | 2 |
| Forsell, P | 1 |
| O'Sullivan, J | 1 |
| Carson, N | 1 |
| Nissinen, A | 1 |
| Luna, RL | 1 |
| Faerchtein, I | 1 |
| de Vasconcelos, EM | 1 |
| Arslanian, L | 1 |
| de La Nuez, SB | 1 |
| Pereira, WQ | 1 |
| Puppin, S | 1 |
| Campos, JC | 1 |
| Roque, AF | 1 |
| Kastansky, I | 1 |
| Cavasinni, L | 2 |
| Poli, L | 3 |
| Davies, IB | 1 |
| Sever, PS | 1 |
| Rosenthal, T | 1 |
| Volan, GN | 1 |
| Rogers, HJ | 2 |
| House, F | 1 |
| Seedat, YK | 1 |
| Grüninger, U | 1 |
| Akert, R | 1 |
| Hunkeler, H | 1 |
| Wegmüller, E | 1 |
| Weidmann, P | 1 |
| Hodler, J | 3 |
| Nysenbaum, A | 1 |
| McFarlane, T | 1 |
| Gadd, RL | 1 |
| Altman, D | 1 |
| Page, RL | 1 |
| Cospite, M | 1 |
| Lo Presti, T | 1 |
| Ferrara, F | 1 |
| Mineo, R | 1 |
| Franz, IW | 1 |
| Lohmann, FW | 1 |
| Jaeger, P | 1 |
| Turini, GA | 1 |
| Jéquier, E | 1 |
| Ferguson, RK | 1 |
| Ebbut, AF | 1 |
| Murphy, JE | 1 |
| Conti, G | 1 |
| Leone, C | 1 |
| Colacurcio, M | 1 |
| Oster, JR | 2 |
| Michael, UF | 2 |
| Perez-Stable, EC | 2 |
| Pearson, RM | 2 |
| Bending, MR | 1 |
| Bulpitt, CJ | 2 |
| George, CF | 2 |
| Hole, DR | 1 |
| Williams, FM | 1 |
| Breckenridge, AM | 1 |
| Colombi, A | 2 |
| Winchester, JF | 1 |
| Ward, DM | 1 |
| McKillop, JH | 1 |
| Kennedy, AC | 1 |
| LaBrooy, J | 2 |
| Munro-Faure, AD | 2 |
| Thomas, GW | 1 |
| Ledingham, JG | 1 |
| Beilin, LJ | 1 |
| Yeates, KM | 1 |
| Rosei, EA | 1 |
| Andersson, O | 2 |
| Berglund, G | 2 |
| Bergman, H | 2 |
| Cramer, K | 2 |
| Fagerberg, SE | 2 |
| Forsberg, SA | 2 |
| Johnsen, V | 2 |
| Lundkvist, L | 2 |
| Rutle, O | 2 |
| Sjolyst, R | 2 |
| Warren, DJ | 1 |
| McLaren, EH | 1 |
| Koch, G | 1 |
| Thomas, RD | 1 |
| Lee, MR | 1 |
| Provvedi, D | 1 |
| Bandinelli, C | 1 |
| Bellini, PG | 1 |
| De Mauro, G | 1 |
| Splendiani, G | 1 |
| D'Alessandro, V | 1 |
| Marinangeli, G | 1 |
| Di Michele, G | 1 |
| O'Brien, KP | 2 |
| Stephens, EJ | 2 |
| Koller, FJ | 1 |
| Goble, AJ | 1 |
| Freeman, JW | 1 |
| Knight, LW | 1 |
| Hansson, L | 1 |
| Werkö, L | 1 |
| Jounela, AJ | 1 |
| Pasanen, M | 1 |
| Mattila, MJ | 1 |
| Cubey, RB | 1 |
| Antalóczy, Z | 1 |
| Dannhorn, R | 1 |
| Müller, AA | 1 |
| Mauracher, EH | 1 |
| Rivier, JL | 1 |
| Henning, H | 1 |
| Crawford, MH | 1 |
| Karliner, JS | 1 |
| O'Rourke, RA | 1 |
| Alexander, WD | 1 |
| Schmieder, RE | 5 |
| Rockstroh, JK | 1 |
| Münch, HG | 1 |
| Schlebusch, H | 1 |
| Dal Palù, C | 3 |
| Fogari, R | 2 |
| Zoppi, A | 2 |
| Tettamanti, F | 1 |
| Poletti, L | 1 |
| Rizzardi, G | 1 |
| Fiocchi, G | 1 |
| Herlitz, H | 1 |
| Pili, G | 1 |
| Basciu, M | 1 |
| Siddi, PP | 1 |
| Tamponi, R | 1 |
| Cherchi, A | 2 |
| Breart, G | 1 |
| Llado, J | 1 |
| Dalle, M | 1 |
| Keller, ME | 1 |
| Goujon, H | 1 |
| Berchel, C | 1 |
| Obel, AO | 2 |
| Kakuk, G | 1 |
| Kurta, G | 1 |
| Kárpáti, I | 1 |
| Mátyus, J | 1 |
| Rugenius, IuIu | 1 |
| Damiĭonaĭtene, RA | 1 |
| Kuchinskene, ZZ | 1 |
| Vidugiris, AI | 1 |
| Steponenene, RV | 1 |
| Pomidossi, G | 1 |
| Parati, G | 1 |
| Malaspina, D | 1 |
| Camesasca, C | 1 |
| Zanchetti, A | 1 |
| Losonczy, I | 1 |
| Fülep, I | 1 |
| Kovács, L | 1 |
| Bähr, M | 2 |
| Schächinger, H | 1 |
| Schulte, W | 3 |
| Zotti, AM | 1 |
| Ambrosio, GB | 1 |
| Vidotto, G | 1 |
| Kukes, VG | 1 |
| Kazarian, AB | 1 |
| Sozinov, VN | 1 |
| Paramonov, LV | 1 |
| Kniazev, RP | 1 |
| Neus, H | 2 |
| Kawecka-Jaszcz, K | 1 |
| Skoczeń, M | 1 |
| Lewis, RV | 1 |
| Jackson, PR | 1 |
| Ramsay, LE | 1 |
| Rigby, JW | 1 |
| Hawksworth, GM | 1 |
| Jamieson, M | 1 |
| Verschueren, J | 1 |
| Niegowska, J | 1 |
| Zawadzki, Z | 1 |
| Pupita, F | 1 |
| Ansuini, R | 1 |
| Belogi, M | 1 |
| Pupita, G | 1 |
| Gaggi, S | 1 |
| Smirnov, GB | 1 |
| Antonaccio, MJ | 1 |
| High, J | 1 |
| DeForrest, JM | 1 |
| Sybertz, E | 1 |
| Dal Negro, RW | 1 |
| Zoccatelli, O | 1 |
| Pomari, C | 1 |
| Trevisan, F | 1 |
| Turco, P | 1 |
| Rueddel, H | 1 |
| Messerli, FH | 1 |
| Harvengt, C | 1 |
| Desager, JP | 1 |
| Heller, F | 1 |
| Hulhoven, R | 1 |
| Stone, JG | 1 |
| Foëx, P | 1 |
| Sear, JW | 1 |
| Johnson, LL | 1 |
| Khambatta, HJ | 1 |
| Triner, L | 1 |
| Alberti, D | 2 |
| Bertoni, T | 1 |
| Peloso, A | 1 |
| Francucci, BM | 1 |
| De Ambroggi, L | 1 |
| Gambini, G | 1 |
| Pizzuti, C | 1 |
| Hill, JF | 1 |
| Fletcher, AE | 1 |
| McInnes, GT | 2 |
| Brodie, MJ | 2 |
| Gonzalez-Gomez, A | 1 |
| Cires Pujols, M | 1 |
| Gamio Capestany, F | 1 |
| Rodriguez de la Vega, A | 1 |
| Garcia-Barreto, D | 1 |
| Traub, YM | 1 |
| Serrurier, D | 1 |
| Bautier, P | 1 |
| Ferrara, LA | 1 |
| Mancini, M | 1 |
| Marotta, T | 1 |
| Pasanisi, F | 1 |
| Fasano, ML | 1 |
| Shmueli, H | 1 |
| Rosenfeld, J | 1 |
| Otten, H | 1 |
| Schmeider, R | 1 |
| Vesanen, K | 1 |
| Baker, JL | 1 |
| Pinto, M | 1 |
| Bradbrook, ID | 1 |
| Babiker, M | 1 |
| Crome, P | 1 |
| Gillies, HC | 1 |
| Morrison, PJ | 1 |
| Shotton, P | 1 |
| Backhouse, CI | 1 |
| Rowley-Jones, D | 1 |
| Spencer-Mills, L | 1 |
| Ocón, J | 1 |
| Oliván, J | 1 |
| Garrido Peralta, M | 1 |
| Ruilope, L | 1 |
| Rodicio, JL | 1 |
| Seco Vasco, J | 1 |
| Rodríguez Alvarez, J | 1 |
| Gras, X | 1 |
| Ross, MR | 1 |
| Collins, R | 1 |
| Chalmers, I | 1 |
| Peto, R | 1 |
| Kyle, MC | 1 |
| Müller, FB | 1 |
| Allsopp, LF | 1 |
| Cooper, GL | 1 |
| Frei, P | 1 |
| Glaus, L | 1 |
| Ritz, R | 1 |
| Lang, R | 1 |
| Jutrin, I | 1 |
| Weiss, Z | 1 |
| Shustak, A | 1 |
| Mines, M | 1 |
| Gotloib, L | 1 |
| Pagnan, A | 1 |
| Thiene, G | 1 |
| Aenishänslin, W | 1 |
| Pestalozzi-Kerpel, J | 1 |
| Dubach, UC | 1 |
| Imhof, PR | 1 |
| Turri, M | 1 |
| Gross, F | 1 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
| Mikhaĭlov, AA | 1 |
| Danil'chenko, MA | 1 |
| Zakharova, AV | 1 |
| Offerhaus, L | 1 |
| Thompson, FD | 1 |
| Joekes, AM | 1 |
| Simpson, FO | 1 |
| Rackensperger, W | 1 |
| Gaupp, R | 1 |
| Mattke, DJ | 1 |
| Schwarz, D | 1 |
| Stutte, KH | 1 |
| Cottier, P | 1 |
| Jänne, J | 1 |
| Keyriläinen, O | 1 |
| Koskinen, P | 1 |
| Leskinen, O | 1 |
| Pitkäjärvi, T | 1 |
| Reinikainen, M | 1 |
| Gysling, E | 2 |
| von Egidy, H | 1 |
| de Wurstemberger, B | 1 |
| Zucchelli, GC | 1 |
| Tuckman, J | 2 |
| Messerli, F | 1 |
| Goldberg, AD | 1 |
| Bulpitt, C | 1 |
| Hole, D | 1 |
| Breckenridge, A | 1 |
| Kunida, H | 1 |
| Hatake, S | 1 |
| Okamoto, M | 1 |
| Majid, PA | 2 |
| Sharma, B | 2 |
| Meeran, MK | 2 |
| Korner, PI | 1 |
| Shaw, J | 1 |
| Uther, JB | 1 |
| West, MJ | 1 |
| McRitchie, RJ | 1 |
| Richards, JG | 1 |
| Benaim, ME | 1 |
| Martin, R | 1 |
| Gilfrich, HJ | 1 |
| Nicolescu, RF | 1 |
| Rahn, KH | 1 |
| Willems, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for oxprenolol and Hypertension
| Article | Year |
|---|---|
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity | 2022 |
Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Atenolol; Coronary Disease; Human | 2017 |
beta-adrenergic blockade and diabetes mellitus. A review.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Glucose; Catecholamines; Diabetes Mellitus, Type 1; D | 1983 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Oxprenolol in clinical practice.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate; Humans; Hyperte | 1983 |
Pregnancy-associated hypertension: interrelationships of volume and blood pressure changes.
Topics: Blood Pressure; Blood Volume; Extracellular Space; Female; Humans; Hypertension; Oxprenolol; Plasma | 1982 |
Beta-adrenoceptor-blocking agents in the management of hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Brain; Cardiac Output; Drug Evaluation; Hea | 1979 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
ACE-inhibitors and quality of life.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Enalapril; Health Status | 1990 |
[Beta-blockers in the therapy of arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Diuretics; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Pre-Ec | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihy | 1974 |
[Beta adrenergic drugs in arterial hypertension].
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Blood Pressure; | 1972 |
136 trials available for oxprenolol and Hypertension
| Article | Year |
|---|---|
Efficacy of nitrendipine as baseline antihypertensive therapy.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Heart Rate; Humans; Hyper | 1984 |
A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Dih | 1984 |
Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Delayed-Action Preparations; Drug Hypersensitivity; | 1981 |
Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Acti | 1981 |
Adrenergic mechanisms in control of plasma lipid concentrations.
Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Fatt | 1982 |
The effect on HDL cholesterol of oxprenolol and atenolol.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, L | 1982 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bendroflumethiazide; Clinical Trials as Topic; Diure | 1984 |
Slow-release oxprenolol compared with oxprenolol in hypertensive patients: a multicenter clinical trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Met | 1983 |
A double-blind study of oxprenolol once and twice daily in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Administration Sche | 1983 |
[Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
Topics: Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydralazine; Hypertensi | 1983 |
United States experience with oxprenolol in hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hy | 1983 |
Clinical responses to oxprenolol in the elderly.
Topics: Aged; Aging; Clinical Trials as Topic; Drug Therapy, Combination; Drug Tolerance; Humans; Hydrochlor | 1983 |
Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients.
Topics: Cardiac Output; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Humans; Hypertensi | 1983 |
Increased plasma vasopressin and serum uric acid in the low renin type of essential hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Catecholamines; Heart Rate; Humans; Hypertension; Male; Middl | 1984 |
Comparison of three different methods of monitoring unwanted effects during antihypertensive therapy.
Topics: Adolescent; Adult; Aged; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Huma | 1984 |
Efficacy of low-dose captopril given twice daily to patients with essential hypertension uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Captopril; Chlorthalidone; Dose-Response Relationship, Dru | 1984 |
Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
Topics: Adult; Blood Pressure; Captopril; Chlorthalidone; Cholesterol; Clinical Trials as Topic; Creatinine; | 1984 |
[Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
Topics: Adult; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Delayed-Action Preparations; Drug C | 1984 |
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Gestational Age; Humans; Hypertension; Methyl | 1983 |
The efficacy of indapamide in hypertensive patients failing to respond to a beta-blocker alone.
Topics: Adult; Aged; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; | 1984 |
Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.
Topics: Atenolol; Dopamine; Epinephrine; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephri | 1983 |
[Evaluation of a delayed-action beta blocker by 24-hour ambulatory recording of the arterial pressure].
Topics: Adult; Blood Pressure; Blood Pressure Determination; Delayed-Action Preparations; Humans; Hypertensi | 1984 |
[Long-term experiences with an antihypertensive combination].
Topics: Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydralazine; Hypertensi | 1982 |
Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Oxprenolol; Posture; Prop | 1982 |
[Evaluation of the hypotensive effect of slow-release Trasicor].
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazi | 1982 |
Relationship of psychological factors to failure of antihypertensive drug treatment.
Topics: Adult; Antihypertensive Agents; Bethanidine; Clonidine; Female; Humans; Hypertension; Male; Methyldo | 1981 |
Long-term treatment with slow release oxprenolol alone, or in combination with other drugs: effects on blood pressure, lipoproteins and exercise performance.
Topics: Blood Pressure; Cholesterol; Delayed-Action Preparations; Drug Therapy, Combination; Fatty Acids, No | 1982 |
Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Heart Rate; Hemodynamics; Humans; Hypertension; Midd | 1980 |
Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Huma | 1980 |
Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Heart Rate; He | 1980 |
Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Topics: Adult; Atenolol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; | 1980 |
Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
Topics: Cholesterol; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Humans; Hyp | 1980 |
Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
Topics: Adult; Aged; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Fe | 1980 |
[Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
Topics: Adult; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hemodynamics; Hu | 1980 |
[Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hyd | 1980 |
Once daily beta-blocker in hypertension--oxprenolol slow-release.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administrat | 1981 |
Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Clinical Trials as Topic; Cyclopenthiazide; Delayed-A | 1981 |
Right ventricular performance in essential hypertension after beta-blockade.
Topics: Clinical Trials as Topic; Double-Blind Method; Heart; Heart Ventricles; Hemodynamics; Humans; Hypert | 1981 |
Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; O | 1981 |
[Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
Topics: Adult; Aged; Chlorthalidone; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Co | 1981 |
A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Pre | 1981 |
The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
Topics: Aged; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Double-Bli | 1981 |
Oxprenolol, methyldopa and lipids in diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Dou | 1982 |
The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
Topics: Adult; Aged; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Dou | 1982 |
Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.
Topics: Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Interactions | 1982 |
A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
Topics: Adult; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Midd | 1982 |
The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.
Topics: Adult; Aged; Double-Blind Method; Extremities; Humans; Hypertension; Middle Aged; Oxprenolol; Propra | 1982 |
Once daily slow-release hydralazine in hypertension.
Topics: Adult; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Oxpren | 1981 |
A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Drug Administration Schedu | 1981 |
Plasma noradrenaline concentration in essential hypertension during long-term beta-adrenoceptor blockade with oxprenolol.
Topics: Adult; Blood Pressure; Electrocardiography; Humans; Hypertension; Middle Aged; Norepinephrine; Oxpre | 1980 |
Effect of oxprenolol on blood pressure, pulmonary ventilatory function and myocardial contractility in hypertensive patients.
Topics: Adult; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Mid | 1980 |
Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Topics: Bendroflumethiazide; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hyperten | 1980 |
Cardiac and haemodynamic measurements in hypertensive pregnancy.
Topics: Adult; Cardiac Output; Echocardiography; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hype | 1980 |
Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cyclopenthiazide; Drug Therapy, Combination; Female; He | 1976 |
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Dose- | 1976 |
The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Depression, Chemical; Female; Humans; Hypertension; Mal | 1976 |
[The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
Topics: Adrenergic beta-Antagonists; Aldosterone; Blood Pressure; Clinical Trials as Topic; Double-Blind Met | 1977 |
Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Depression, Chemical; Female; Heart Ra | 1979 |
[Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Diuretics; Drug Therapy, Combination; | 1979 |
Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evalua | 1976 |
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Evaluatio | 1977 |
[An example of an acceptable combination in the treatment of arterial hypertension].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydralazine; Double-Blind Method; Drug Combinations; Drug E | 1978 |
Hydrallazine with beta-blocker and diuretic in the treatment of hypertension. A double-blind crossover study.
Topics: Adult; Aged; Cyclopenthiazide; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; | 1979 |
[2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
Topics: Adult; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Evaluation; Drug Therapy, Combina | 1977 |
Bethanidine and oxprenolol in hypertension--a study in combination therapy.
Topics: Adolescent; Adult; Aged; Bethanidine; Clinical Trials as Topic; Drug Therapy, Combination; Guanidine | 1977 |
Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
Topics: Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Drug Eva | 1977 |
The transient anti-hypertensive effect of phentolamine in patients receiving beta-blocker treatment.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combinati | 1977 |
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
Topics: Adult; Airway Obstruction; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trials as Topic; Dou | 1978 |
Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Hypertension; Ma | 1977 |
A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Female; Heart Rate; Humans; Hype | 1978 |
A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hum | 1979 |
Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Met | 1978 |
A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
Topics: Alprenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Ev | 1979 |
Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
Topics: Adult; Aged; Atenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Meth | 1979 |
Hemodynamic effects of oxprenolol and propranolol in hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Heart Rate; He | 1979 |
Antihypertensive effect of oxprenolol and chlorthalidone in fixed combination, given once daily.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug | 1979 |
Labetalol in the treatment of hypertension in general practice.
Topics: Clinical Trials as Topic; Diuretics; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; M | 1979 |
Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
Topics: Adult; Aged; Alprenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1979 |
[Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
Topics: Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; | 1979 |
Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.
Topics: Blood Pressure; Humans; Hydralazine; Hypertension; Norepinephrine; Oxprenolol; Posture; Reflex; Reni | 1979 |
Can once daily dosage be effective in the treatment of hypertension throughout 24 hours? A controlled evaluation of sustained release oxprenolol.
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Hypertension; Male; Mi | 1979 |
Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Blood Glucose; Creatinine; Female; Humans; Hypertension; Methyldopa; Oxprenolol | 1979 |
Antihypertensive effectiveness of oxprenolol administered twice daily.
Topics: Administration, Oral; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Administration Sched | 1976 |
Trial of combination of guanethidine and oxprenolol in hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Guanethidine; Heart Rat | 1976 |
Antihypertensive effects of oxprenolol and propranolol.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Humans; Hydrochlorot | 1976 |
Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.
Topics: Clinical Trials as Topic; Dihydralazine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Syn | 1975 |
Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension.
Topics: Adult; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Evaluation; Drug Therapy, Combin | 1976 |
Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dose-Response Relati | 1976 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Humans; Hypertension; Male; Methyldopa; M | 1976 |
The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
Topics: Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hyp | 1976 |
Effect of oxprenolol on catecholamines and plasma renin activity: acute response to frusemide in hypertensive patients.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Interactions; Epinephrine; Furosemide; Heart R | 1975 |
Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prop | 1976 |
[Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
Topics: Adult; Clinical Trials as Topic; Diarrhea; Dyspnea; Female; Humans; Hypertension; Male; Middle Aged; | 1975 |
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Forced Expiratory Volume | 1990 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidon | 1990 |
A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension.
Topics: Adult; Birth Weight; Cesarean Section; Dihydralazine; Double-Blind Method; Drug Therapy, Combination | 1990 |
Efficacy and tolerability of long term oxprenolol and chlorthalidone singly and in combination in hypertensive blacks.
Topics: Adult; Black People; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Delayed-Action Prepar | 1990 |
[Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor].
Topics: Adult; Antihypertensive Agents; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; | 1990 |
Antihypertensive effect of a new formulation of slow release oxprenolol in essential hypertension.
Topics: Adult; Antihypertensive Agents; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertensio | 1987 |
Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
Topics: Adrenergic beta-Antagonists; Adult; Black People; Blood Pressure; Chlorthalidone; Clinical Trials as | 1989 |
Efficacy of four antihypertensive drugs (clonidine, enalapril, nitrendipine, oxprenolol) on stress blood pressure.
Topics: Adult; Blood Pressure; Blood Pressure Determination; Clinical Trials as Topic; Clonidine; Enalapril; | 1989 |
Disparities in blood pressure control under various antihypertensive regimens.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Clonidine; Enalapril; Exercis | 1989 |
Predictors of blood pressure increases after withdrawal of antihypertensive therapy.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Oxpr | 1985 |
Myocardial infarctions and cerebrovascular accidents in relation to blood pressure control. The IPPPSH Collaborative Group.
Topics: Adult; Cerebrovascular Disorders; Death, Sudden; Double-Blind Method; Female; Humans; Hypertension; | 1985 |
Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; | 1985 |
A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Hyper | 1985 |
Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Clinical Trials as Topic; Electrocardiography | 1985 |
Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Atenolol; Chlorthalidone; Drug Therapy, Combination; | 1986 |
Disparate hemodynamic responses to mental challenge after antihypertensive therapy with beta blockers and calcium entry blockers.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Calcium Channel Blockers; Heart Rate; Hemodynamics; Hum | 1987 |
Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Anesthesia; Atenolol; Clinical Trials as To | 1988 |
[Comparison of the effects of oxprenolol and nifedipine on blood pressure at rest and during physical exercise in essential hypertension].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Exercise; Female | 1988 |
Angiotensin converting enzyme inhibitors and quality of life: the European trial.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, | 1985 |
Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
Topics: Administration, Oral; Adult; Blood Pressure; Delayed-Action Preparations; Exercise; Female; Heart Ra | 1988 |
Impact of antihypertensive therapy on blood pressure reactivity during mental stress.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clonidine; Hemodynamics; Humans; Hypertension; Magne | 1988 |
Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Delayed- | 1988 |
Crossover design to test antihypertensive drugs with self-recorded blood pressure.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Clinical Tria | 1988 |
Concentration-effect relationships for oxprenolol in patients with essential hypertension.
Topics: Adult; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Hypertension; Male; Middle Ag | 1988 |
Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Drug Interacti | 1986 |
[A multicenter clinical comparison study between Tevacor and Trasicor in hypertension].
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Male; | 1986 |
Disparate effects of initial antihypertensive therapy on well-being.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Male | 1987 |
Electrocardiographic changes during antihypertensive therapy in the International Prospective Primary Prevention Study in Hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Electrocardiography; Female; Heart Diseases; Humans; Hypert | 1987 |
Hydrochlorothiazide and triamterene with sustained-release oxprenolol in the treatment of hypertension.
Topics: Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidn | 1986 |
[Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
Topics: Adult; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; H | 1985 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Ne | 1985 |
The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Delayed-Action Preparation | 1985 |
[Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Blood Pressure; Catatonia; Clinical Trials as Top | 1974 |
[Treatment of arterial hypertension using beta-blockaders].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hyperten | 1974 |
Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combinat | 1974 |
Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
Topics: Chlorothiazide; Clinical Trials as Topic; Drug Synergism; Furosemide; Heart Rate; Hydralazine; Hyper | 1973 |
Hypotensive effect of oxprenolol in mild hypertension: a co-operative controlled study.
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Drug Interactions; Drug Synergism; F | 1973 |
Proceedings: Clinical studies: beta-blockade in systemic hypertension.
Topics: Benzothiadiazines; Clinical Trials as Topic; Cyclic S-Oxides; Cyclopentanes; Diuretics; Humans; Hype | 1974 |
Proceedings: A trial of the combination of guanethidine and oxprenolol in hypertension.
Topics: Clinical Trials as Topic; Drug Combinations; Drug Synergism; Guanethidine; Humans; Hypertension; Oxp | 1974 |
Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
Topics: Adult; Aged; Benzothiadiazines; Clinical Trials as Topic; Cyclic S-Oxides; Cyclopentanes; Diuretics; | 1973 |
Oxprenolol in hypertension.
Topics: Adult; Aged; Blood Pressure Determination; Clinical Trials as Topic; Female; Humans; Hypertension; M | 1973 |
[Clinical effect of a beta receptor blockader, oxprenolol, in hypertension--its relationship with renin-aldosterone activities].
Topics: Adolescent; Adult; Aldosterone; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle | 1974 |
150 other studies available for oxprenolol and Hypertension
| Article | Year |
|---|---|
An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cyclopenthiazide; Diuretics; Drug Combinations; Female; | 1980 |
[Effect of changes of posture, beta-blocking agents and the cold pressure test on the levels of plasma renin activity (PRA) in essential hypertension with low serum renin].
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cold Temperature; Female; Humans; Hypertension; | 1980 |
[Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients].
Topics: Adrenergic beta-Antagonists; Age Factors; Chlorthalidone; Diuretics; Drug Combinations; Drug Evaluat | 1980 |
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Drug Therapy, Combination | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relation | 1980 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Me | 1983 |
[Test with the use of the adrenergic beta receptor blockader trasicor in the differential diagnosis of arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; H | 1983 |
Oxprenolol in the treatment of hypertension in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Diuretics; Female; Hemod | 1983 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growt | 1984 |
Beta blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Kinetics; Methyldopa; Oxprenolo | 1984 |
Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Ventricles; Hydrochlorothiazide; Hypertens | 1983 |
Acute psoriatric arthropathy precipitated by oxprenolol.
Topics: Arthritis; Drug Eruptions; Female; Humans; Hypertension; Middle Aged; Oxprenolol; Psoriasis | 1984 |
[Evaluation of the efficacy of various hypotensive drugs in broad-breasted white turkeys as an experimental model of arterial hypertension with high catecholamine levels].
Topics: Animals; Antihypertensive Agents; Captopril; Catecholamines; Disease Models, Animal; Furosemide; Hyp | 1983 |
Studies with long acting propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Delayed-Action Preparations; Half-Life; Heart Rate; Humans; H | 1984 |
Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk.
Topics: Adolescent; Adult; Female; Humans; Hypertension; Infant, Newborn; Maternal-Fetal Exchange; Milk, Hum | 1984 |
Effects of moderate salt restriction in hypertensive patients treated with oxprenolol or chlorthalidone.
Topics: Adult; Aged; Blood Pressure; Chlorthalidone; Diet, Sodium-Restricted; Female; Heart Rate; Humans; Hy | 1984 |
[Slow-release oxprenolol and chlortalidone administered once daily in essential hypertension].
Topics: Adult; Chlorthalidone; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hypertension; | 1984 |
Excretion of oxprenolol and timolol in breast milk.
Topics: Adult; Female; Humans; Hypertension; Infant, Newborn; Milk, Human; Oxprenolol; Timolol | 1983 |
Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
Topics: Adult; Blood Pressure; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle | 1983 |
Effect of prazosin on blood pressure and plasma lipids in patients receiving a beta-blocker and diuretic regimen.
Topics: Aged; Blood Pressure; Chlorthalidone; Cholesterol; Drug Therapy, Combination; Female; Humans; Hypert | 1984 |
[Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
Topics: Adult; Blood Pressure Determination; Chlorthalidone; Delayed-Action Preparations; Drug Combinations; | 1984 |
The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
Topics: Adult; Aldosterone; Amiloride; Blood Pressure; Body Weight; Diuretics; Drug Combinations; Female; Hu | 1982 |
Trasicor versus methyldopa in Pakistani hypertensive patients: a comparative study of efficacy and tolerability.
Topics: Chlorthalidone; Drug Therapy, Combination; Humans; Hypertension; Methyldopa; Oxprenolol; Pakistan | 1981 |
[Withdrawal syndrome following beta blocker therapy (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Middle Aged; Myocard | 1981 |
Prazosin and oxprenolol therapy in pregnancy hypertension.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Oxprenolol; Prazosin; Pregn | 1983 |
The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Cyclopenthiazide; Heart Rate; Humans; Hypertension; M | 1983 |
Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Drug Combinations; Family Pra | 1980 |
Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80.
Topics: Antihypertensive Agents; Bed Rest; Benzothiadiazines; Birth Weight; Diuretics; Drug Therapy, Combina | 1982 |
Effects of digoxin on plasma renin activity in hypertensive patients.
Topics: Adult; Digoxin; Drug Therapy, Combination; Furosemide; Half-Life; Humans; Hypertension; Male; Middle | 1980 |
Treatment of mild to moderate hypertension: diuretic or beta-blockers?
Topics: Adult; Age Factors; Blood Pressure; Humans; Hypertension; Middle Aged; Oxprenolol; Pindolol; Plasma | 1981 |
Disposition of oxprenolol in spontaneously hypertensive rats as determined by an enzyme immunoassay.
Topics: Administration, Oral; Animals; Galactosidases; Galactosides; Hypertension; Immunoenzyme Techniques; | 1981 |
[Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. II. Metoprolol and oxprenolol].
Topics: Adult; Blood Flow Velocity; Blood Viscosity; Female; Humans; Hypertension; Male; Metoprolol; Middle | 1982 |
[Slow-release hydralazine in the treatment of essential arterial hypertension].
Topics: Adult; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hydralazine; Hypertension; Male; | 1982 |
[Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
Topics: Adult; Aged; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Oxp | 1980 |
Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Double-Blind Method; Hemodyna | 1981 |
Effects of chronic beta-blockade on intra-arterial blood pressure during motor car driving.
Topics: Adult; Automobile Driving; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Phys | 1981 |
Effects of treatment on circadian rhythms of blood pressure.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Circadian Rhythm; Heart Rate; Humans; Hypertensio | 1981 |
Cardiovascular responses to acute and subchronic treatment with oxprenolol in spontaneously hypertensive rats at rest and at stress.
Topics: Animals; Blood Pressure; Electrodes, Implanted; Heart Rate; Hypertension; Male; Oxprenolol; Rats; Ra | 1981 |
[Slow trasicor in the treatment of essential hypertension].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Oxp | 1981 |
Circadian rhythms in hypertension.
Topics: Adult; Blood Pressure; Circadian Rhythm; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1981 |
Comparative study of acebutolol and oxprenolol in the management of hypertensive cerebrovascular diseases (CVD) patients.
Topics: Acebutolol; Adult; Aged; Antihypertensive Agents; Central Nervous System; Cerebrovascular Disorders; | 1981 |
One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
Topics: Adult; Aged; Chlorthalidone; Delayed-Action Preparations; Drug Combinations; Female; Heart Rate; Hum | 1981 |
[Clinical value of selective beta 1 block in antihypertensive therapy].
Topics: Adult; Atenolol; Female; Humans; Hypertension; Male; Oxprenolol; Pindolol; Propanolamines | 1981 |
Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
Topics: Adult; Aged; Blood Pressure; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Dose-Response | 1980 |
Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
Topics: Chlorthalidone; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Ma | 1980 |
[Combined action of oxprenolol, hydrochlorothiazide and hydralazine in rats with metacorticoid induced hypertension].
Topics: Animals; Desoxycorticosterone; Drug Evaluation; Drug Therapy, Combination; Hydralazine; Hydrochlorot | 1980 |
Oxprenolol in pregnancy.
Topics: Female; Humans; Hypertension; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1980 |
Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly.
Topics: Acromegaly; Adult; Aged; Female; Glucose; Growth Hormone; Humans; Hypertension; Male; Middle Aged; O | 1980 |
[Treatment of hypertension with a new combination of beta blocking agents and saluretics].
Topics: Chlorthalidone; Delayed-Action Preparations; Drug Combinations; Hypertension; Oxprenolol | 1980 |
The management of hypertension in pregnancy.
Topics: Adult; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hypertension; Oxprenolol; Prazosin; | 1981 |
[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Echocardi | 1994 |
The management of hypertension with special reference to debrisoquine and beta blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Debrisoquin; Diuretics; Female; Humans; Hy | 1976 |
Raynaud's phenomenon as side effect of beta-blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Hypertension; Male; Methyldopa; Middle | 1976 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metopro | 1976 |
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Catecholamines; Diuretics; Humans; | 1976 |
Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bethanidine; Blood Pressure; Debrisoquin; Drug Therapy | 1976 |
Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
Topics: Adrenergic beta-Antagonists; Adult; Aging; Aldosterone; Angiotensin II; Antihypertensive Agents; Blo | 1976 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
Relative importance of cardioselectivity and partial agonism in the treatment of hypertension in the patient with air-flow obstruction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Airway Obstruction; Heart; Humans; Hypertensi | 1979 |
Plasma concentration and antihypertensive effect of beta-receptor blockers.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Drug Evaluation; Heart Rate; Humans; Hypertension; Oxpr | 1979 |
Editorial: Adrenergic-neuron and beta-receptor blockade in hypertension.
Topics: Antihypertensive Agents; Debrisoquin; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertensi | 1976 |
Inappropriate antihypertensive therapy in the elderly.
Topics: Age Factors; Aged; Antihypertensive Agents; Cyclopenthiazide; Drug Therapy, Combination; Humans; Hyp | 1976 |
[Treatment of hypertension with a combination of beta receptor blockers and diuretics (Trasitensin retard)].
Topics: Adult; Aged; Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Oxp | 1979 |
Effects of inflammatory disease on plasma oxprenolol concentrations.
Topics: Adult; Aged; Arthritis, Rheumatoid; Back Pain; Blood Sedimentation; Chronic Disease; Crohn Disease; | 1979 |
Letter: Effects of beta-adrenergic blockade with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Pro | 1975 |
[Antihypertensive therapy using beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiac Output; Heart Rate; Humans; Hypertension; Hypertens | 1975 |
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Blood Pressure; Female; Hemodynamics; Humans; Hyper | 1975 |
Once daily administration of a beta-blocker in hypertension.
Topics: Adult; Aged; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Hypertension | 1978 |
Experience with a slow-release formulation of oxprenolol.
Topics: Blood Pressure; Delayed-Action Preparations; Drug Administration Schedule; Humans; Hypertension; Oxp | 1978 |
Improvement in foetal growth with treatment of maternal hypertension in pregnancy.
Topics: Birth Weight; Female; Humans; Hypertension; Infant, Newborn; Oxprenolol; Pregnancy; Pregnancy Compli | 1978 |
Blood pressure circadian rhythm in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Middle Aged; Oxprenolol | 1978 |
[Interrelationships between renin and arterial pressure in subjects with essential hypertension under diuretic treatment: effect of addition of oxprenolol and indomethacin].
Topics: Diuretics; Electrolytes; Female; Humans; Hypertension; Indomethacin; Male; Oxprenolol; Renin | 1978 |
The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension.
Topics: Adolescent; Adult; Blood Pressure; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle A | 1977 |
Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
Topics: Cyclopenthiazide; Diuretics; Humans; Hypertension; Methyldopa; Oxprenolol; Sodium Chloride Symporter | 1979 |
Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
Topics: Cyclopenthiazide; Drug Evaluation; Hypertension; Methyldopa; Oxprenolol; Research Design | 1979 |
[Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
Topics: Adult; Aldosterone; Blood Pressure; Diuresis; Drug Therapy, Combination; Female; Humans; Hypertensio | 1979 |
Fetal hazards of altering hypotensive regimens in pregnancy.
Topics: Adult; Female; Fetal Distress; Humans; Hypertension; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Co | 1979 |
Experience with sustained-release oxprenolol (slow trasicor) in the management of hypertension in general practice.
Topics: Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged | 1979 |
The acute and chronic effects of oxprenolol on ambulatory blood pressure and heart rate in essential hypertension [proceedings].
Topics: Blood Pressure; Heart Rate; Humans; Hypertension; Oxprenolol; Time Factors | 1979 |
A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
Topics: Antihypertensive Agents; Blood Pressure; Body Weight; Cyclopenthiazide; Delayed-Action Preparations; | 1979 |
Progressive pleural thickening during oxprenolol therapy.
Topics: Adult; Humans; Hypertension; Male; Oxprenolol; Pleural Diseases; Radiography | 1979 |
[Effect of oxprenolol on the plasma renin activity in essential arterial hypertension].
Topics: Adult; Drug Evaluation; Hemodynamics; Humans; Hypertension; Middle Aged; Oxprenolol; Renin | 1977 |
A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice.
Topics: Adult; Aged; Delayed-Action Preparations; Drug Evaluation; Humans; Hypertension; Middle Aged; Oxpren | 1978 |
[Ergometry in the assessment of antihypertensive treatment (author's transl)].
Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Female; Humans; Hydralazine; Hypertension; Mal | 1978 |
[Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
Topics: Adult; Aldosterone; Chlorthalidone; Female; Furosemide; Hirsutism; Humans; Hypertension; Male; Middl | 1978 |
Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
Topics: Adult; Aged; Blood Pressure; Cyclopenthiazide; Diuretics; Drug Combinations; Female; Humans; Hyperte | 1978 |
Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Fa | 1978 |
[Oxoprenolol and plasmatic renin activity in essential hypertension: preliminary data].
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Physical Exertion; Posture; Reni | 1978 |
The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
Topics: 17-Ketosteroids; Adult; Aldosterone; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Hype | 1978 |
Beta-adrenergic receptor blockade and renal function.
Topics: Adult; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Long-Term Care; Male; Oxprenolol; Prop | 1976 |
Beta blockade in essential hypertension: an analysis of response to oxprenolol.
Topics: Adult; Age Factors; Aged; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension | 1977 |
Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol.
Topics: Adult; Drug Interactions; Humans; Hypertension; Hypertension, Renal; Male; Methyldopa; Oxprenolol; P | 1976 |
Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent.
Topics: Adult; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypert | 1976 |
Sodium repletion and beta-adrenergic blockade in treatment of salt depletion with accelerated hypertension.
Topics: Humans; Hypertension; Hyponatremia; Male; Middle Aged; Oxprenolol; Sodium | 1976 |
[Comparative study of the hypotensive effect of a combination of oxprenolol-chlortalidone with single and fractionated administration].
Topics: Adult; Aged; Chlorthalidone; Drug Administration Schedule; Drug Combinations; Female; Humans; Hypert | 1976 |
[Treatment of hypertensive uremic patients in hemodialysis with beta blockers].
Topics: Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Practolol; Renal Dialysis | 1976 |
Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
Topics: Adult; Aged; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Hypertension | 1976 |
Once daily dosage beta-blockade: antihypertensive efficacy of slow release oxprenolol as related to renin and age.
Topics: Adolescent; Adult; Age Factors; Delayed-Action Preparations; Diuretics; Female; Humans; Hypertension | 1976 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
Topics: Humans; Hypertension; Methyldopa; Oxprenolol; Pindolol; Posture; Propranolol; Renin; Spironolactone | 1976 |
Comparison of a slow-release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
Topics: Adult; Aged; Delayed-Action Preparations; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolo | 1976 |
Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
Topics: Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Mid | 1975 |
Oxprenolol and hydrallazine in the treatment of hypertension.
Topics: Adult; Diuretics; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Methyl | 1975 |
[Treatment of hypertension with beta blocking agents].
Topics: Alprenolol; Drug Therapy, Combination; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1975 |
Acetylator phenotype and the antihypertensive response to hydralazine.
Topics: Acetylation; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydralazine; Hyper | 1975 |
Ocular reaction to propranolol and resolution on continued treatment with a different beta-blocking drug.
Topics: Eye Diseases; Female; Humans; Hypertension; Middle Aged; Oxprenolol; Propranolol | 1975 |
The use of Trasicor and hypothiazide in the treatment of hypertension and hypertensive angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Humans; Hypertension; Oxprenolol | 1975 |
[Ambulatory treatment of arterial hypertension urinary the new combination "saluretic and beta-sympatholytic"].
Topics: Chemical Phenomena; Chemistry; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; | 1975 |
[Treatment of essential hypertension with Transicor 80 and Esidrex K under medical practice conditions].
Topics: Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Oxprenolol | 1976 |
Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
Topics: Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Male | 1976 |
Beneficial effects of nitroglycerin on abnormal ventricular wall motion at rest and during exercise in patient with previous myocardial infarction.
Topics: Adult; Aged; Drug Therapy, Combination; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; | 1976 |
Letter: Guanethidine in hypertension.
Topics: Drug Therapy, Combination; Guanethidine; Humans; Hypertension; Oxprenolol | 1976 |
Elevated serum activity of N-acetyl-beta-glucosaminidase in essential hypertension: diagnostic value and reversal to normal values after antihypertensive therapy.
Topics: Acetylglucosaminidase; Adult; Age Factors; Blood Pressure; Body Weight; Clinical Enzyme Tests; Femal | 1991 |
Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Calcium-Transporting ATPases; Cardiomeg | 1990 |
Use of tensiomin (captopril) in the antihypertensive treatment of haemodialysis patients.
Topics: Adult; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Female; Guanfacine; Guanidines | 1990 |
Examination of the cardioprotective effect of Trasicor-80 in primary health care.
Topics: Angina Pectoris; Cardiac Complexes, Premature; Humans; Hypertension; Middle Aged; Oxprenolol | 1986 |
[Type A behavior and psychological characteristics of hypertensive patients undergoing antihypertensive treatment].
Topics: Aged; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; | 1989 |
[Central effects of beta adrenergic receptor blockaders, obsidan and trasicor, in arterial hypertension].
Topics: Adult; Alpha Rhythm; Brain; Electroencephalography; Humans; Hypertension; Male; Middle Aged; Oxpreno | 1989 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hy | 1985 |
A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atenolol; Blood Proteins; Female; Half-Life; | 1985 |
[Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hypertension; Lipids; Male; Metoprolol; Mi | 1985 |
[Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination | 1986 |
Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Blood Pressure; Decerebrate St | 1986 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hyper | 1987 |
[Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
Topics: Adult; Cardiomegaly; Chlorthalidone; Delayed-Action Preparations; Drug Therapy, Combination; Exercis | 1986 |
Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiomegaly; Chlorthalidone; Creatinine; Delayed-Action | 1988 |
The influence of monotherapy with oxprenolol and nitrendipine on ambulatory blood pressure in hypertensives.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Human | 1985 |
Relationships between verapamil plasma concentrations and its antihypertensive action.
Topics: Adult; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Hear | 1988 |
Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.
Topics: Adult; Age Factors; Aged; Blood Proteins; Delayed-Action Preparations; Drug Evaluation; Female; Huma | 1986 |
Antihypertensive treatment in pregnancy.
Topics: Female; Humans; Hypertension; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1985 |
Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Electrocardiography; Humans; Hydralazine; Hydroc | 1985 |
Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; | 1985 |
Tolerance to oxprenolol.
Topics: Drug Tolerance; Female; Humans; Hypertension; Middle Aged; Oxprenolol | 1985 |
Evidence of reduced atherosclerotic lesions in broad breasted white turkeys treated with oxprenolol.
Topics: Aging; Animals; Aorta, Abdominal; Arteriosclerosis; Blood Pressure; Disease Models, Animal; Heart Ra | 1985 |
Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Body Weight; Heart Rate; Human | 1972 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
[Experience in the treatment of hypertensive states with beta-blockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Humans; Hypertension; Hypertension, Renal; Mid | 1973 |
Proceedings: Combined alpha and beta-receptor blockade in the treatment of severe hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Drug Synergism; Humans; Hypertension; Oxp | 1974 |
Proceedings: General practitioner studies of beta-blockade in hypertension.
Topics: Adrenergic beta-Antagonists; Benzothiadiazines; Cyclic S-Oxides; Cyclopentanes; Diuretics; Drug Syne | 1974 |
Letter: Beta-blockade in the presence of renal disease and hypertension.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Humans; Hypertension; Kidney; Oxprenolol; Proprano | 1974 |
Beta-blockade for hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Oxprenolol; | 1974 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |
[Effects of combined treatment with hydrochlorothiazide and oxprenolol on arterial pressure and activity of plasma renin. Preliminary results].
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; H | 1974 |
The effect of clonidine on plasma renin activity in human hypertension.
Topics: Adult; Body Weight; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Phentola | 1973 |
Combined alpha and beta adrenergic blockade in treatment of hypertension.
Topics: Cardiac Output; Heart Rate; Humans; Hypertension; Oxprenolol; Phentolamine; Physical Exertion | 1973 |
Autonomic and non-autonomic circulatory components in essential hypertension in man.
Topics: Adolescent; Adult; Atropine; Autonomic Nervous System; Blood Pressure; Body Surface Area; Cardiac Ou | 1973 |
Proceedings: Oxprenolol in mild to moderate essential hypertension.
Topics: Humans; Hypertension; Oxprenolol | 1974 |
Editorial: Hypertension and the community.
Topics: Humans; Hypertension; Mass Screening; Middle Aged; Oxprenolol; Propranolol; Scotland | 1974 |
Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.
Topics: Administration, Oral; Adult; Cardiac Output; Depression, Chemical; Drug Synergism; Female; Heart Rat | 1974 |
[Treatment of hypertension with high doses of oxprenolol alone or in combination with the vasodilator dihydralazine].
Topics: Amino Alcohols; Cardiac Output; Diuretics; Drug Synergism; Humans; Hydralazine; Hypertension; Oxpren | 1972 |
[Studies on the antihypertensive effect of propranolol and oxprenolol in man].
Topics: Adult; Blood Pressure; Cardiac Output; Humans; Hypertension; Oxprenolol; Propranolol | 1971 |